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Serologic and Clinical Manifestations of Chlamydial Infection in Children with
Mycoplasma Pneumonia. T. Nishimura, K. Tabuki, T. Takashima, K. Hiromatsu.
Osaka Medical College, Takatsuki, Osaka, Japan
The serologic and clinical manifestation of infection with Mycoplasma pneumoniae were
studied in children during the three years from October 1979 to December 1981.
Pneumonia was diagnosed in 107 of the 430 patients with lower respiratory tract infections;
mycoplasma pneumonia was diagnosed in 52 ofthese 107 (20 males and 32 females aged one to
14 years). See Fig. 1.
By single serology, seropositive was defined as more than 64 times (80 times) that of
mycoplasma CF (HA) titer and more than 32 times that of chlamydia CF titer.
By repeated serology, chlamydial infection demonstrated by fourfold or greater rise in com-
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FIG. 1. Age distribution of patients with mycoplasma
infection (October 1979-December 1981).
FIG. 2. Clinical and laboratory
findings in patients with pneumonia.
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FIG. 3. Distribution ofchlamydial antibodies by age in














FIG. 4. History ofexposure to birds
in patients with pneumonia.
plement fixation titer to Chlamydia psittaci was confirmed in 12 of the 52 patients with
mycoplasma pneumonia.
Clinically, the duration of cough and fever did not differ significantly between the
mycoplasma pneumonia group and the mixed infection group; however, the titer peaked in
the mixed infection group a little earlier (Fig. 2). Serum CRP concentrations were high in the
latter.
Clinical and laboratory findings were not exceptional in the nine patients with chlamydial in-
fection.
Chest X-rays showed pneumonia shadows mainly in the right lower lobe of the lung in the
mycoplasma pneumonia cases, but there were no characteristic shadows in the mixed infection
group. The duration ofpneumonia shadows in the mycoplasma pneumonia group was shorter
than in the mixed infection group.
The patients with positive chlamydial antibodies frequently had a history ofexposure to pet
birds and others (see Figs. 3 and 4). Our data suggest that chlamydial infection is frequent inpatients with mycoplasma pneumonia. The isolation of Chlamydia psittaci in mycoplasma
pneumonia is necessary for diagnosing chlamydial infection in mycoplasma pneumonia.
Concomitant Rise in Serum Antibody to Mycoplasma pneumoniae and Viruses in
Pediatric Patients with Respiratory Infections. Yasutaka Niitu, Shigeo Komatsu,
Ken Suzaki, Masahiro Horikawa, Masahiko Terawasa, Sawa, Tatsuo Miyaji,
Tomiko Suetake. The Research Institute for Tuberculosis and Cancer, Tohoku Uni-
versity, Sendai, Japan; and Ryo Chiba. Sendai Red Cross Hospital, Sendai, Japan
We studied the concomitant rise in serum antibody to M. pneumoniae and to viruses in 202
pediatric patients with respiratory infections who showed rise in serum antibody to M. pneu-
moniae, with or without positive isolation of M. pneumoniae, and were diagnosed as having
M. pneumoniae infection in 1975 to 1981. The paired or serial sera which were drawn from the
patients and were verified to be elevated in complement-fixing (CF) and/or indirect hemag-
glutinating (IHA) antibody to M. pneumoniae during the disease were tested in microtiter
plates for CF antibody to influenza virus A and B, adenovirus type 3, and respiratory syncytial
virus and for hemagglutination-inhibiting antibody to parainfluenza virus types 1, 2, and 3 and
to mumps virus.
Of the 202 patients with M. pneumoniae respiratory infections, the concomitant antibody
rise to viruses was observed in 25 (12 percent). The viruses for which the concomitant antibody
rise was observed and the number of patients are shown in Table 1. Of the 25 patients, an-
tibody to M. pneumoniae rose earlier in oAie and later in one than antibody to virus. Others
showed simultaneous antibody rise to M. pneumoniae and virus in serial or paired sera. As pa-
tients with concomitant rise in serum antibody grouped at definite periods, the concomitant
rise was considered to indicate that M. pneumoniae infection and virus infection occurred
simultaneously or very nearly so.
The concomitant antibody rise was observed in 9(45 percent) of 20 patients below two years
ofage, in 12 (12 percent) of 98 patients of two to six years, and in 4(5 percent) of 84 patients of
seven to 15 years, indicating a higher percentage at lower ages; the concomitant antibody rise
was observed in 7(6 percent) of1I13 patients with positive isolation ofM. pneumoniae, in con-
trast to 18 (20 percent) of 89 patients with negative isolation, and in 18 (12 percent) of 156 pa-
tients with pneumonia.
The symptoms and clinical findings were not clearly different between the group with the
concomitant antibody rise to viruses and the group without it (Table 2). The duration of
pneumonia on X-ray film was a little longer in patients with concomitant antibody rise to virus
at an age of less than four years, whereas it was similar between the two groups at the age of
four years or more.
TABLE 1
Viruses to Which Antibody Rose Concomitantly
No. of children with antibody rise to M. 202
pneumoniae tested for antibody to virus
Antibody rise to virus 25(12%)
Influenza virus type A I
Adenovirus 6
Parainfluenza virus type 1 I
type3 4
type Iand3 1
type 1, 2, 3 and mumps virus I
type 2 and mumps virus I
Adenovirus and parainfluenza virus type 3 1
Mumps virus 2
Respiratory syncytial (RS) virus 7
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Reports on the Concomitant Virus Infection in Pediatric Patients with M. pneumoniae Infection
Viruses which caused
No. of concomitant infection
patients with Diagnostic basis for
M. pneumoniae No. of
infection patients M. pneumoniae
Author Year (age in years) (M0) Viruses infection Virus infection
Foy et al. 1973 22 9 RS virus 4 Antibody rise





Nishida 1978 201 5 Measles 5 CF Clinical
et al. (0-15) (3)
Nagayama 1981 292 43 RS virus 22 Serology?




Present 1982 202 25 Antibody rise Antibody rise
author (0-15) (12)
Repeated Infections with M. pneumoniae in Three Children. Yasutaka Niitu, Tat-
suo Miyaji, Ken Suzaki, Shigeo Komatsu, Masahiro Horikawa, Masahiko Tera-
sawa, Tomiko Suetake. The Research Institute for Tuberculosis and Cancer, To-
hoku University, Sendai, Japan
We previously reported that in most children serum antibody elevated by M. pneumoniae in-
fection waned after several months. It is probable that repeated infections occur in children for
years. However, only a few cases ofrepeated infections have been documented. In Sendai two
epidemics of M. pneumoniae infection occurred, showing peaks in 1976 and 1980. We ob-
served three children who received two infections during the two epidemic periods.
Case I A girl showed M. pneumoniae infection first at six years of age and second at ten
years. At the time of the first infection she had pneumonia with cough and fever; M. pneu-
moniae was isolated. Serum complement-fixing (CF) and indirect hemagglutinating (IHA) an-
tibody rose. At the second infection she had cough and throat pain without fever. M. pneu-
moniae was isolated and serum fermentation-inhibiting (FI) antibody rose.
Case 2 A boy acquired M. pneumoniae infection first at six years of age and second at ten
years. At the time of the first infection he had pneumonia, which was discovered in a mass
chest X-ray survey. He had no fever, but serum Fl antibody rose. At the second infection he
had cough and fever. M. pneumoniae was isolated and serum Fl antibody rose.
Case 3 A boy showed M. pneumoniae infection first at ten years of age and second at 16
years. At the time ofthe first infection he had pneumonia with cough and fever; serum Fl, CF,
and IHA antibodies rose. At the second infection he complained ofcough and fever, but chest
X-ray findings were normal. M. pneumoniae was isolated. Serum Fl and IHA antibodies rose.
In all ofthese cases the symptoms were so mild at the second infection that chest X-rays were
not done for two patients. Sera drawn from the patients serially between the two infections and
initially at the second infection showed Fl antibody to be below 1:4, with which the second in-
fection was probably associated.
In Sendai, outbreaks of M. pneumoniae infection occurred every four years. Sera drawn
from six children serially over two or more epidemic years were tested for CF, Fl, and IHA an-
858 POSTER SESSIONStibodies. No antibodies were found in any of the sera. Of the children without antibody, some
showed a second infection, while some had no infection, thus indicating the mildness ofthe M.
pneumoniae epidemic.
Strictly Four-Year Periodicity of Outbreaks of M. pneumoniae Infections and
Antibiotic Sensitivity of M. pneumoniae Isolates in Sendai. Yasutaka Niitu, Ken
Suzaki, Tatsuo Miyaji, Masahiro Horikawa, Shigeo Komatsu, Masahiko Terasawa,
Tomiko Suetake. The Research Institute for Tuberculosis and Cancer, Tohoku
University, Sendai, Japan
For the past 29 years mass chest photofluorographic surveys have been made in May and
June of every year among pupils of the primary, middle, and high schools in Sendai. The an-
nual study population was about 70,000 from 1954 to 1973, and about 30,000 from 1974 to
1982, when the surveys of pupils of several grades were stopped. Every year the incidence of
pneumonia was highest in the first year of primary school (six years of age) and decreased with
increasing age. M. pneumoniae infections have been studied by serology and isolation since
1960. The percentage of M. pneumoniae pneumonia for all pneumonias found in the surveys
displayed a four-year cycle, highest in 1964, 1968, 1972, 1976, and 1980, and lowest in 1966,
1970, 1974, and 1978. The annual incidence ofM. pneumoniae pneumonia found in the surveys
also fluctuated in a manner quite similar to the annual percentage of M. pneumoniae pneu-
monia.
The number of children who were diagnosed in our clinic as having M. pneumoniae infec-
tions was largest every four years, in 1968, 1972, 1976, and 1980, and smallest in 1966, 1970,
1974, and 1978, every year halfway between epidemic years. During every epidemic, the pa-
tients increased from the latter half of the year prior to the epidemic year, peaked from July to
December of the epidemic year, and gradually decreased from the beginning of the next year.
M. pneumoniae was isolated in 8 to 12 percent of about 70 children less than six years old in
a day nursery in Sendai, in November and December 1980 and January 1981, and suddenly
could not be isolated from March 1981 on, when pediatric patients with M. pneumoniae infec-
tions decreased in our clinic. Isolation was attempted seven times more to July 1982 but was
always negative.
The results revealed that the outbreaks of M. pneumoniae infection have had a strictly four-
year periodicity in Sendai for the past 22 years.
Sensitivity to erythromycin (EM), josamycin (JM), tetracycline (TC), and streptomy-
cin (SM) was tested in 505 first isolates of M. pneumoniae recovered from 505 patients from
1965 to 1981. EM resistance was observed in 3 (0.6 percent). The resistance was assumed to
have developed because of administration of EM before the isolation. Resistance to SM was
observed in 11 isolates (3 percent) before 1979 but in none of 135 isolates thereafter. No iso-
lates were resistant to TC and minocycline.
Development of resistance to an antibiotic in M. pneumoniae after therapy with that anti-
biotic was studied from 1965 to 1981. After antibiotic therapy of more than a week the isolates
had developed resistance to EM in three of 39 patients, to JM in four of 18, and to the TC
group in none of 16, as compared with the isolates before the therapy.
Though M. pneumoniae acquires resistance to macrolide antibiotics during therapy with the
drug in some patients, we do not need, at present, to consider infection with M. pneumoniae
primarily resistant to antibiotics, but need to watch the problem carefully.
A Survey of Immunological Responses in Patients with M. pneumoniae Infections.
Hiromichi Mizutani, Hiroko Mizutani. Institute of Medical Information, The
Kanto Teishin Hospital, Tokyo, Japan
Serological responses in patients with M. pneumoniae infections were analyzed by means of
enzyme-linked immunosorbent assays (ELISA), density gradient centrifugation, and so on.
The serological survey forIgM and IgG antibodies using ELISA disclosed two patterns of an-
tibody prevalence: IgM antibody levels did not differ over all age groups, whereas IgG an-
tibody levels had a tendency to increase with age. The serum titer of IgG to the pathogen was
found to be low in infants, occasionally high in age groups 4 to 15 years, and high in all sub-
jects over 16 years.
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Further analysis ofthe sera by treatment with protein A followed by fractionation by sucrose
density gradient centrifugation, which had been conducted to assess the specificity of the lgM
antibody, revealed the presence of rheumatoid factor with a remarkably high frequency in the
sera of patients with M. pneumoniae infections. Selected patients were followed, during the
clinical course oftheillness, by determining their serum IgM and IgG antibody titers and serum
concentration of rheumatoid factor; it was shown that the concentrations of the rheumatoid
factors of some patients in the early days of the illness were much higher than that of the spe-
cific IgM antibodies.
It had been reported that rheumatoid factors appeared in the circulation of patients with
miscellaneous infections such as tuberculosis and influenza, but there had been no report ofits
demonstration in patients with M. pneumoniae infections.
The demonstration of rheumatoid factor in the present study might be attributed to a higher
degree of sensitivity of the ELISA as compared to the routine assay system, e.g., latex agglu-
tination test, and so on. Although the detailed significance of rheumatoid factor in this infec-
tion is not yet known, its remarkably frequent prevalence and its change in accordance with the
course of the illness indicate that the rheumatoid factor has also something to do with this in-
fection.
Long-Term Field Study of Naturally Acquired Immunity to Mycoplasma pneu-
moniae. H.M. Foy, G.E. Kenny, M.K. Cooney, I.D. Allan, G. van Belle. University
of Washington, School of Public Health and Medicine, Seattle, Washington
Patients with culture-proven M. pneumoniae pneumonia were followed with serum collec-
tion at 18-month intervals. Comparison groups without known M. pneumoniae pneumonia
were followed with annual serum collection. Complement fixation (antilipid) antibodies were
detectable for two to nine years after an episode ofM. pneumoniae pneumonia but usually fell
sharply after the second year in infected persons who did not have pneumonia. Reinfection was
rare in patients with a history of M. pneumoniae pneumonia but occurred frequently in age-
matched controls without adiagnosis ofpneumonia. Pneumonia was rarely reported at the sec-
ond infection. Children who acquired M. pneumoniae antibodies during infancy had no worse
experience ofM. pneumoniae infections at school age than those without serologic evidence of
early infection.
The current study suggests that naturally acquired infection induces partial immunity to M.
pneumoniae infection, and that such immunity lasts longest for those who manifest pneu-
monia. The study did not shed light as to why some persons develop clinically recognizable
pneumonia when infected, since pneumonia occurred both at first known and second exposure
to the organism. There was no evidence of sensitization to M. pneumoniae due to exposure
early in life.
Preparation of Monoclonal Antibodies Against Mycoplasmas, Acholeplasmas, and
Spiroplasmas. G.J. McGarrity. Institute for Medical Research, Camden, NJ
R. Kennett. University ofPennsylvania, Philadelphia, PA F. Megraud. University
of Bordeaux II, Bordeaux, France D. Buck. University of Pennsylvania, Phila-
delphia, PA
Specific monoclonal antibodies have been prepared against Mycoplasma orale MG, M.
hyorhinis GDL, M. pneumoniae FH, M. arginini VA, M. salivarium VV, Acholeplasma
laidlawii JS, Spiroplasma citri R8A2, and the corn stunt spiroplasma isolate E. BALB/c mice
received three intraperitoneal injections, each of 10'-108 CFU of triply washed organisms.
Three days after the last injection, spleen cells were hybridized with SP2/0-Agl4/8 aza-
guanine-resistant mouse myeloma cells using polyethylene glycol MWIQ00. Selection was in
HAT medium. Proliferating hybrids were selected for production of antimycoplasmal anti-
bodies by ELISA, using peroxidose-conjugated antimouse immunoglobulin. For ELISA
screening ofhybridoma supernatants, wells ofpolyvinyl chloride plates were coated with poly-
D-lysine (0.1 mg per ml of PBS) and incubated for 0.5 hour at room temperature when the
poly-D-lysine was removed. 100-200 ng ofmycoplasmal protein determined by Lowry assay of
the appropriate triply washed mycoplasma was added to each well in volumes of 50I1. Plates
were incubated at 37°C for four hours. Organisms were fixed with 0.5 percent glutaraldehyde for
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0.5 hour at room temperature. Plates were washed two times with PBS, and residual glutaral-
dehyde activity was blocked by 100 mM glycine in 0.1 percent bovine serum albumin for 0.5
hour at room temperature.
Specificity was investigated against a minimum of six heterologous species and other strains
of the homologous species, using ELISA, growth inhibition, and immunofluorescence. A
minimum of four clones for each mycoplasmal species was selected for further study. Anti-
body class was identified; most were IgG, but two clones were IgM producers. For example,
antibody classes of five clones of hybridomas producing antibodies to M. salivarium are: Y2aX,
3YX, XX, 72: , _YX [1]. ELISA titers ofculture supernatants ranged from 1:128 to 1:1024; ELISA
titers of ascites or sera from hybridoma tumor-bearing BALB/c mice ranged from
1.2 x 10- to 4 x 106. These monoclonal antibodies have been effectively used to identify other
strains, including wild types, in cell cultures and in broth. Controlled prospective studies are in
progress to determine the efficacy of these reagents in identification of mycoplasmas isolated
from cell cultures, clinical material, and plant material.
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Immunochemical Characterizations of Surface Peptides of Ureaplasma urealyti-
cum. G.W. Stemke, J.A. Robertson. University of Alberta, Edmonton, Alberta,
Canada
Isolates of Ureaplasma urealyticum from human genital sources have shown antigenic
heterogeneity, and this heterogeneity has led to the establishment of serotyping schemes. At-
tempts to date to use serotyping to distinguish virulent and avirulent isolates in our hands have
not been conclusive; i.e., U. urealyticum isolated from individuals with and without non-
gonococcal urethritis have shown nearly the same distribution of serotype specificities. How-
ever, the serotype patterns havebeenquite complexand we may be detecting common orshared
specificity. In an attempt to better understand the chemical basis for serotype specificity, and,
we hope, to be able to improve specificity, we are attempting to characterize the surface struc-
tures carrying the antigenic specificities.
We have surface-labeled U. urealyticum T960-Cx8 (serotype 8) using lactoperoxidate-
catalyzed iodination with I2'1 and have analyzed the complex mixture by a variety of methods:
crossed immunoelectrophoresis, followed by radioautography, one- and two-dimensional
PAGE. These experiments indicate that several "surface" peptides/proteins are iodinated (in-
cluding horse serum proteins from the medium) and four or five precipitin peaks can be de-
veloped using antiserotype 8. Only one very faint precipitin is radioactive. This may represent a
serotype antigen.
The method of two-dimensional PAGE of unlabeled U. urealyticum, serotype 8 followed by
electrophoretic transfer or Electro-Blot to cellulose nitrate membranes has been done to allow
immunological identification of certain of the two-dimensional peptide patterns. Tlle major
surface peptide set (based upon the results with surface-labeled ureaplasma) reacts with neitlher
antihorse serum nor with antiserotype 8, as detected by subsequent reaction with '2ll-labeled
goat antirabbit IgG and radioautography. Different conditions for the isoelectric focusing step
of the two-dimensional PAGE have been examined in an attempt to preserve antigenicity,
without further success.
A method used by J. Swanson for gonococcus [Infection and Immunity 34:804-816, 1981],
which involves the formation of immune complexes with surface-labeled cells and the sub-
sequent extraction of the complexes with Zwittergent 3-14, also failed to extract any labeled
antigens.
In all cases much of the radioactivity could not be dissociated to soluble peptides, even with
SDS and 2-mercaptoethanol treatment. This material was largely susceptible to digestion with
trypsin or even more so with pronase, and thus seems to be protein/polypeptide, or glyco-
peptide. Both proteolytic enzymes, but particularly trypsin, yielded digests which included
macromolecular labeled components. While serotype antiserum could not be blocked by a
trypsin digest, in future work very limited digestion might liberate "soluble" materials wllichi re-
tain reactivity.862 POSTER SESSIONS
Characterization of Mycoplasma pneumoniae Antigens After Phagocytosis by
Guinea Pig Alveolar Macrophages. E. Jacobs, M. Kist. Institute for General Hy-
giene and Bacteriology, Center for Hygiene, University of Freiburg, Freiburg,
Federal Republic of Germany
Antibody-opsonized Mycoplasmapneumoniae cells labeled with different radioactive mark-
ers were sedimented on to monolayers of guinea pig alveolar macrophages (AM). The occur-
rence of phagocytosis was proven by use of fluorochrome-labeled mycoplasmas and by elec-
tron microscopy. After phagocytosis the activity of3H-palmitic acid-labeled mycoplasmas was
only slowly released into the supernatant. About 98 percent of it remained AM-associated up
to eight hours later whereas 3H-thymidine- and 3H-amino-acid-labeled substances were found
to be 50-70 percent in the supernatants within eight hours. Supernatants and AM were tested
for M. pneumoniae antigen with ELISA. Considerable amounts of antigenically active material
could be found in the supernatant within eight hours. It was inactivated by heat and trypsin
treatment. These antigens were further characterized by transferring the electrophoretically
separated protein patterns to nitrocellulose sheets. These proteins were identified by antigeni-
anti M. pneumoniae-IgG '25J-protein A complexes. After phagocytosis, antigellically active
cytoplasmic proteins of M. pneumoniae were found in the supernatant and bound to
macrophages, whereas membrane proteins were bound to macrophages and could not be
detected in the supernatant.
Isolation of Antigen of Mycoplasmapneumoniae Responsible for Indirect Hemag-
glutination Activity. S. Kobayashi, S. Kanegasaki, J.Y. Homma. The Institute of
Medical Science, The University of Tokyo, Tokyo, Japan
Introduction: Mycoplasmapneumoniae is known to be a causative agent ofprimary atypical
pneumonia. Although antibodies developed in humans infected with the mycoplasma can be
demonstrated by several immunological methods, the antigen responsible for indirect hemag-
glutination (IHA) has not been characterized. In this report we show that the antigen (hapten)
responsible for IHA can be extracted from the membrane of M. pneumoniae and separated
from the hapten responsible for complement fixation (CD) by a one-step operation ofbutanol-
water extraction.
Materials andMethods: Membrane fraction obtained from French-pressed M. pneumoniae,
which was grown in Chanock's medium supplemented with fetal calf serum, was mixed vigor-
ously with an equal volume of n-butanol. After centrifugation at 4,000 rpm for 15 minutes,
TABLE 1
Titration of Mycoplasma Extracts in Complement Fixation Test
Cell equivalent Dilution of antiserum
Extract (x 10') 40 80 160 320 640 1,280 2,560
Membrane 1 (12 ig protein) + + + + + + + + + + + + -
0.5 ++ ++ ++ ++ ++ + _
0.25 ++ ++ ++ ++ + - -
0.125 ++ ++ ++ + - _ _
0 + - _ _ _ _ _
Butanol layer 4 + + + + + + + + + + +
2 ++ ++ ++ ++ ++ + _
I +++ ++ ++ ++ + -
0.5 ++ ++ ++ + - - -
0 + - - _ _ _ _
Water layer 4 (16,gg protein) + +
2 ++ +
- _ _ _ _
I + + + -
0.5 ++ + - - - - -
0 + - - _ _ _ _POSTER SESSIONS 863
three layers were obtained: upper butanol, middle, and lower water layers. After removing the
butanol, each layer was subjected to the tests of CF and IHA activity, using rabbit antiserum
against M. pneumoniae or serum obtained from the patients.
Results andDiscussion: As shown in Table 1, a butanol layer containing lipids reacted effi-
ciently with the antiserum in the CF test, whereas the water layer did not react with the anti-
serum. In contrast, IHA activity was found to be present in the water layer and not in the
butanol layer (Table 2).
The IHA antigen in the water layer was partially purified using DEAE cellulose column and
characterized further. Trypsin, pronase, and alkaline protease from B. subtilis all destroyed
the IHA activity. Treatment at 80°C for 20 minutes reduced the activity by three orders ofdilu-
tion and treatment at 100°C for 20 minutes destroyed the activity completely. DNase and
RNase did not affect the activity.
These results suggest that the antigen responsible for IHA is at least in part protein in nature.
Since the IHA test is more sensitive than the CF test, the IHA test may be useful for laboratory
diagnosis.
TABLE 2
Titration of Mycoplasma Extracts in Indirect Hemagglutination Test
Cell equivalent Dilution of antiserum
Extract (x 107) 40 80 160 320 640 1,280 2,560 5,120
Membrane 1 (12 tg protein) + + + + + + + + + + + + -
0.5 + + - - - - - -
0.25 + - _ - _ _ _ _
0 - - - _ _ _ _ _
Butanol layer 4
2 - - - _ _ _ _ _
1 - - - _ _ _ _ _
0.5 - - - - - - - -
0 - - - _ _ _ _ _
Waterlayer 4(16jtgprotein) ++ ++ ++ ++ + + + -
2 ++ ++ ++ ++ + + _ _
1 ~~++ + - _ _ _ _ _
0.5 + - - - - - - -
0 - - - _ _ _ _ _
Effect of Mycoplasma pneumoniae and Some of Its Fractions on Host Defense
Mechanisms. H. Brunner. Institute for Chemotherapy, Bayer AG, Wuppertal, Fed-
eral Republic of Germany; and J. Beck, H. Kirchner. Institute of Virus Research,
German Cancer Research Center, Heidelberg, Federal Republic of Germany
Mycoplasma pneumoniae is the most common cause of atypical pneumonia at times when
influenza A virus infections are not prevalent. This has stimulated great efforts for develop-
ment of a potent vaccine against M. pneumoniae disease. Furthermore, in recent years the
host-parasite relationship in M. pneumoniae infections has attracted considerable attention,
especially when evidence was provided that the immune response might in part contribute to
the lung infiltrates [Brunner H, et al: J Infect Dis 127:S52, 1973; Fernald GW, Clyde WA Jr:
INSERM 33:421, 1974]. It has been shown before that repeated intranasal inoculation of M.
pneumoniae in guinea pigs resulted in a decrease in the number of colony-forming units in the
lung and in the upper respiratory tract, indicating protection. In contrast, the extent of lung in-
filtrates increased with the number of inoculations. This showed that potent protective
mechanisms were established in the respiratory tract and that this defense was connected with
more intense lung infiltrates [Brunner H: Reviews of Infectious Diseases 4:S239, 1982]. These
findings gain importance in considering the feasibility of immunoprophylaxis.
We have previously shown that prior inoculation of Mycoplasma pneumoniae polysac-charides protected hamsters against homologous infection with virulent organisms [Brunner
H, Prescott B: In Seminars in Infectious Disease, Vol IV: Bacterial Vaccines. Edited by L
Weinstein, BN Fields. New York, Thieme-Stratton Inc, 1982, pp 190-197]. Intranasal as well
as intramuscular instillation of polysaccharides induced protection, but a much higher dose
was needed for a similar degree ofprotection after intramuscular as compared to intranasal ad-
ministration, supporting the concept of the importance of local immunity for prevention of
M. pneumoniae disease in humans [Brunner H, et al: Infect Immun 8:612, 1973]. Since Naot et
al. [Reviews of Infectious Diseases4:S272, 1982] had shown pathogenic potential ofnon-viable
M. pulmonis in the rat lung, we investigated the question of whether M. pneumoniae poly-
saccharides or membrane proteins exhibit similar properties in experimental animals. Hamsters
and guinea pigs were studied because both species are susceptible to M. pneumoniae infection
and subsequently develop lung infiltrates. Significant lymphocyte infiltrations were observed
five to 24 hours after intranasal administration ofpolysaccharides into guinea pigs but not into
hamsters. No lesions were seen after instillation of membrane protein.
Because it had been demonstrated by Biberfeld et al. [Nature 260:238, 1976], that M. pneu-
moniae is a polyclonal B-cell activator of mouse spleen cells, we exposed splenic lymphocytes
of various mouse strains to M. pneumoniae and its fractions. Polysaccharides and, to a lesser
degree, membrane proteins of the organisms stimulated the incorporation of 3H-thymidine
into mouse spleen cells. In addition, M. pneumoniae was able to induce interferon production
in mouse spleen cells.
In this context it was of interest to learn if fractions of the organisms will reach organs other
than the respiratory tract during M. pneumoniae disease. We have therefore inoculated
hamsters intranasally with organisms which had been labelled with '4C-oleic acid and 14C-pal-
mitic acid. The amount of radioactivity decreased in the lung, but increased at the same time in
fat tissue, liver, kidney, and brain. The distribution of radioactive material was entirely dif-
ferent when a mixture of the fatty acids was inoculated intranasally. We can therefore specu-
late that the unspecific influence of M. pneumoniae on immune mechanisms might not be
limited to the respiratory tract during infection.
Influence of Alveolar Macrophage Cytotoxicity of Phagocytized and Cell-
Membrane-Associated Mycoplasmas. M. Kist, H. Koster. Institute for General
Hygiene and Bacteriology, Center for Hygiene, University of Freiburg, Freiburg,
Federal Republic of Germany
After phagocytosis of opsonized Mycoplasma pneumoniae (M.p.), cultured guinea pig
alveolar macrophages (AM) release heat- and trypsin-sensitive mycoplasma substances. Mostly
heat-resistant mycoplasma antigens remain associated with the AM monolayer [Kist M, et al:
Infect Immun 36:357-362, 1982]. The potential biological activities of these substances could
include coating and heterogenization of host cell membranes, rendering these cells more
susceptible to the attack of humoral or cell-mediated immunologic mechanisms, as well as the
activation of AM by undigestible antigenic material, augmenting cytotoxic features of the
phagocytic cell.
Precultivated or freshly harvested AM were activated by phagocytosis of either M.p. an-
tigen, opsonized, or native M.p. cells. The two target cell lines F9/41 (mouse teratoma) and L
1210 (mouse lymphoma) were incubated with sonicated M.p. antigen in PBS (pH 7.0) and the
attachment was controlled by immunofluorescence. In other experiments, target cells were co-
cultivated with living M. pneumoniae over a 48-hour time period. The interaction of effector
cells (EC) and target cells (TC) was investigated in a cytotoxicity assay (EC:TC = 10:1) using
"Se-methionine labeled target cells. The advantages of the "S5e-system were high specific ac-
tivity (2-4 cpm/cell) and low radioactive baseline release (20-30 percent in 48 hours).
Twenty hours after incubation of the target cells withfreshly harvestedAM alone about 15
percent of the total radioactivity was released. When opsonized M.p. was present during the
cytotoxicity assay or when the phagocytes were preactivated by phagocytosis of opsonized
M.p., the "Selenium release increased to 30 percent or 60 percent, respectively. The cytotoxic
effect (CE) of preactivated AM occurred more rapidly if compared with the CE of AM acti-
vated during the assay. After four hours supernatants ofpreactivated AM produced a CE com-
parable with that of the cells themselves, but this activity was markedly reduced at 20 hours.
AMprecultivatedfor20 hours exhibited no significant cytotoxicity against target cells. How-
ever, when such phagocytes were preactivated by opsonized or native M.p. for two or40 hours
864 POSTER SESSIONSthe release increased to 30 percent or 50 percent, respectively, of the total activity. Activation
of AM by sonicated M.p. antigen was less effective; however, ifanti-M.p.-antibody was added
after antigen treatment, the CE was increased significantly. The cytotoxic activity of the effec-
tor cells could be significantly inhibited by 2-deoxy-d-glucose (5 x10-2M). Anltibioticsinhlibit-
ing mycoplasma protein synthesis were not effective.
Target cells heterogenized with mycoplasma antigen weresignificanltly more senlsitive to AM
than native TC. During a 20-hour assay they released about 40 percent oftheir total radio-
activity (control 20percent) but an amplification of this toxic effect by theanitigen attachmenit
procedure alone could not be completely ruled out. Co-cultivation of TC togetlher with living
M.p. for 48 hours was more effective, resulting in 60 percent release after 20 hours ofincu-
bation with freshly harvested AM.
The results suggest increased cytotoxic effects if mycoplasmas are preselnt in aphagocyte-
target cell system. This can be considered as a potential factor of tissue destruction in vivo.
Localization and Characterization of the Binding Sites of Mycoplasmapneumoniae
by Use of a Monoclonal Antibody. J. Feldner, W. Bredt. Institute for General
Hygiene and Bacteriology, University of Freiburg, Freiburg, Federal Republic of
Germany
The human respiratory pathogen Mycoplasmapneumoniae adheres to a variety of eukaryo-
tic cells and to inert surfaces such as glass and plastic. The latter property is the basis for the
gliding motility of this species. By use of a mouse hybridoma-derived monoclonalantibody
which inhibited both adherence of erythrocytes to M. pneumoniae and attachment of this
species toglass, it waspossible to localize and characterize the binding sites on the mycoplasma
membrane surface. Immunofluorescence staining of glass-grown mycoplasmas resulted in a
polar fluorescence, indicating that the isolated antibody reacted specifically with the tip struc-
ture of the M. pneumoniae cell. Immunoferritin experiments confirmed this observation by
electron microscopy [U. Gobel]. The antibody caused no growth inhibition, had no titer in the
metabolic inhibition test, and was not able to mediate complement lysis. The lack of these
properties is probably due to the peculiar localization oftheantigenl. However, themotility of
M. pneumoniae was inhibited by low concentrations; theshape of the cells wasnot affected. Ac-
cording to immunodiffusion and gel chromatography, the antibody belonged to theIgM class.
In the gel electrophoresis pattern of M. pneumoniae proteins the corresponding antigen was
localized at 160-190 K by use of35S-labeled antibody.
The results provide evidence that the mechanisms of erythrocyte adherence, glass attach-
ment, andmotility operate via similar or identical molecules. Apparently the bindingsubstance
is not evenly distributed throughout the mycoplasma cell surface but is primarily associated
with the specialized tip structure of M. pneumoniae.
Relationship Between the Stimulation Index of Lymphocytes and the Extent of Le-
sions inMycoplasmapneumoniae Pneumonia. 0. Kitamoto, H. Kobayashi. Kyorin
University School of Medicine, Mitaka, Tokyo, Japan; and S. Nakamura. Kama-
kura Clinic, Yokohama, Kanagawa, Japan
It has been known that lymphocytes taken from patients with Mycoplasma pneumoniae
pneumonia are stimulated and transformed in vitro by the specificantigeni, asan expressioni of
cell-mediated immunity.
This report shows that the degree of cell-mediated immunity, measured by the lymphocyte
stimulation, and the severity of pneumonia, measured by the extent of X-ray shadow in the
lung, have some correlation.
Materials andMethods: Study subjects: twenty-two adultpatients with serologicallyproven
M. pneumoniae pneumonia, 13 males and nine females, were included in this study.
Methods: Clinical signs and symptoms of the patients were observed, and chest X-ray
photographs were taken once or twice a week throughout the course of illness.
Serum specimens for humoral antibody titration and lymphocytes forstimulation tests were
taken at least twice in the acute stage of illness and in convalescence.
Humoral antibody was measured by the complement fixation test (CF) and the indirect
hemagglutination test (IHA).














Extent of Pulmonary Shadow
FIG. 1. Lymphocyte response and extent
of pulmonary X-ray shadow.
The lymphocyte stimulation test was done.
Mycoplasma antigen used in the test was prepared. The degree of lymphocyte response was
evaluated and expressed by the stimulation index (SI).
Results: The relation between the stimulation index and the extent of lesions in M.
pneumoniae pneumonia was noted as shown in Fig. 1. In cases of extensive shadows (larger
than one segment of the lung) SI values were higher. In cases of moderate or minor shadows
(smaller than one segment and smaller than a few lobules, respectively), SI values were lower.
The difference between the group of extensive shadows and the group of moderate or minor
shadows is significant by the t test (p < 0.05). No humoral antibody titers-neitlher CF nor
IHA titers-had definite correlation with the extent of pulmonary slhadows.
Summary: It is suggested that cell-mediated immunity miglht be more closely related than
humoral immunity to the extent of lesions in patients with M. pneumoniae pneumoniia.
Problems and Results with ELISA inMycoplasmapneumoniaeSerology. E. Jacobs,
C. Thomssen. Institute for General Hygiene and Bacteriology, Center for Hygiene,
University of Freiburg, Freiburg, Federal Republic of Germany
Methods using the complement fixation test for serological diagnosis ofM. pneumoniae in-
fections in human sera are based on glycolipid antigens. These lipids, however, are not species-
specific, and cross-reactions with various groups of microorganisms, plants, and host tissues
have been described. Until now, only a little has been known about the antigenic specificity of
M. pneumoniae proteins. In this study an ELISA test was used, based on sonicated M. pneu-
moniae cells for antigen. Preliminary results with human sera of adults without acute disease
showed high titers, whereas low titers were found in children. To investigate the possible cause
of high titers in adults, M. pneumoniae proteins were separated electrophoretically. The pro-
tein patterns were either transferred to nitrocellulose sheets or eluted out of the polyacryl-
amide gel matrix after electrophoresis. The transferred protein patterns were incubated withl
sera of M. pneumoniae infected and non-infected patients. Antigeni-antibody complexes were
identified by 123J-protein A. These sera were also tested by enzyme-linked immunosorbelnt
assay (ELISA) and results were compared with sonicated mycoplasma suspensiolns and
separated M. pneumoniae protein.
Detection of M. pneumoniae Antibodies by Single Radial Complement Fixation
Test (SRCF). K. Jo, S. Sekine, S. Sato. Denka Institute of Biological Science, To-
kyo, Japan
A stabilized modification of the single radial complement fixation test (SRCF) in gel was
developed for routine diagnosis of Mycoplasma pneumoniae infection. The principle of the
test is characterized by its single-step procedure with the following reagents: (1) agarose platePOSTER SESSIONS 867
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FIG. 1. Principle of SRCF with thin complement
film.
containing antigen and antibody coated erythrocyte (EA), and (2) thin plastic film coated with
dried complement (Fig. 1).
Theprocedure: The well on the agar is filled with 10 ul of tested sera (diluted 1:4 and inac-
tivated), and thin complement film is placed on the surface of the agar. The diameter of the
non-hemolytic zone appearing around the well after incubation (16-20 hours at 4°C, and 2-3
hours at 37°C) is read as the result (Fig. 2). The square ofthediameter iscompared with the CF
titer conventionally tested.
The CF antigen of M. pneumoniae was prepared from liquid culture of FH-Liu strain with
Chanock's media, which was concentrated 20 times by centrifugation, sonicated, and inac-
tivated at 600C, for 20 minutes.
For obtaining the type-specific control serum by immunizing guinea pigs, special antigen was
prepared from liquid culture with Taylor-Robinson's media [1], containing rabbit infusion
broth and serum.
Fifty-eight patient sera containing paired samples were collected and tested for the experi-
ments.
The procedure is very simple to use and good correlation of CF titer was observed between
the SRCF and conventional CF tests with patient sera (Fig. 3). The antibody increase in paired
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Comparison of SRCF Titers in Serum Specimens of
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1. Taylor-Robinson D, et al: J Bact 85:1261, 1963Detection of Antibodies to Mycoplasma hominis and Ureaplasma urealyticum by
Enzyme-Linked Immunosorbent Assay (ELISA). M.B. Brown, G.H. Cassell. Uni-
versity of Alabama in Birmingham, Birmingham, AL; D. Taylor-Robinson. Medi-
cal Research Council Clinical Research Center, Harrow, Middlesex, England;
W.M. McCormack. Channing Laboratory, Harvard Medical School, Boston, MA;
and M.C. Shepard. Naval Medical Research Laboratory, Camp LeJeune, NC
The optimum conditions for ELISA detection of human IgG, IgM, and IgA antibodies to
M. hominis and U. urealyticum were established using cell lysate antigens and affinity-purified
alkaline phosphatase conjugates as follows: antigen, 20jig protein/ml; sera diluted 1:200, and
conjugates diluted 1:500 (IgA) and 1:750 (IgG, IgM).
The M. hominis ELISA was compared in a blind study with the complement-dependent
mycoplasmacidal (MC) test for detection ofpresence ofantibody as well as change in antibody
levels in acute and convalescent sera from women with postpartum fever of suspected
mycoplasmal origin. The MC and ELISA were highly correlated (p < .002, N = 27). ELISA
results were independent of the M. hominis strain used as antigen.
The U. urealyticum ELISA was compared in a blind study with the metabolism inhibition
(MI) assay using normal sera and that from men with nongonococcal urethritis (NGU). Agree-
ment between the two tests with respect to presence ofantibody was 82 percent and 95 percent
for acute and convalescent sera, respectively. Serum antibody responses were serotype-
dependent in the MI test but not in the ELISA. The magnitude of change between acute and
convalescent sera was greater for NGU patients than for normal asymptomatic ureaplasma-
positive male controls. A significant change in antibody levels for one or more antibody class
was detected for 12 of 18 (67 percent) NGU patients by ELISA. Ten of the twelve (83 percent)
individuals had a change in the IgM class which is suggestive of an active infectious process.
Due to the ubiquity of M. hominis and U. urealyticum in normal, healthy individuals,
evidence for serological specificity must be somewhat indirect. Prior antigen exposure with
subsequent clearance oforganisms may result in seropositive yet culturally negative individuals
whose sera can be interpreted as either false positives or cross-reactions. The presence of spe-
cific antibody was significantly associated with cultural isolation of the appropriate
microorganism for both theM. hominis(p < .001) and U. urealyticum(p < .001) ELISAs. In
addition, theELISA results correlated with otherestablished serological tests in the two patient
groups studied.
As a further test of specificity, rabbit antisera to M. hominis, U. urealyticum serotypes 1-8,
Mycoplasma pneumoniae, Mycoplasma salivarium, Mycoplasma fermentans, and Myco-
plasma orale were tested for cross-reactions. No significant cross-reactions were observed be-
tween M. hominis rabbit serum and heterologous mycoplasmal ELISA antigens. However, a
one-way cross-reaction was observed between anti-ureaplasmal rabbit serum to all serotypes
and M. hominis antigen. This cross-reaction was not attributable to medium components since
(i) all antigens used for antiserum production were grown using rabbit, not horse, serum,
(ii) thecross-reaction was one wayonly, (iii) no reaction was observed when sterilemedium was
used as the ELISA antigen, and (iv) broth-injected control rabbits did not react with the
ELISA antigen. The relevance of this one-way cross-reaction seen in rabbits to potential cross-
reactions in humans is difficult to evaluate. However, in 26 individuals with high (> 1.9 A400
units) ELISA values for U. urealyticum, 17 (74 percent) had significantly lower or negative
ELISA values (<.9 A400 units) in the M. hominis ELISA. This data suggests that the cross-
reaction observed in rabbits may not extrapolate to the human immune response; however, the
possibility that some individuals may possess cross-reacting antibodies cannot be excluded.
These preliminary studies indicate that ELISA may be a useful tool in elucidating the class-
specific immune response in U. urealyticum and M. hominisinfections. The ELISA is easier to
perform than othercommonly usedserological tests; however, in order for the ELISA to detect
serotype or strain differences a more highly purified ELISA antigen will be required.
Clinical Analysis of the Fashion of Progression ofMycoplasmapneumoniae Infec-
tion of the Lung. T. Natsuizaka. Minami Ichi-jo Hospital, Sapporo, Japan A.
Suzuki. Sapporo Medical College, Sapporo, Japan
Materials andMethod: Twenty-three cases ofserologically proven Mycoplasmapneumoniae
infection with radiological evidence of pulmonary involvement were evaluated roentgeno-
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logically to analyze the site of the lesion and the fashion of progression with special reference
to pulmonary segmental anatomy. Stress was focused not only on abnormal shadows but also
on the obliterated silhouette of pulmonary vascular shadows.
Results: The progression of lesions was divided into three stages and Stage X.
The lesions were roentgenologically started in peribronchial and peripulmonary arterial
interstitium in roentgenologically observable order-Stage 1. Characteristically, the changes in
Stage 1 did not present obvious abnormal densities on routine posteroanterior radiographs but
could be detected as obscured pulmonary arterial silhouette with thickened bronchial walls of
accompanying bronchi (Fig. 1).
These changes in Stage 1 were fundamental followed by alveolitis in both the surrounding
and distal regions-Stage II. These lesions were observed on roentgenograms as soft band-like
densities of various widths along bronchial trees, according to the degree ofprogression of le-
sions.
With increase in interstitial tissue reaction, an alveolar exudate was finally produced-Stage
III. The roentgenogram presented inhomogeneous, relatively high density with mottling
shadows.
The peripheral subpleural region, especially in Stage I and Stage II, roentgenologically
tended to be free of lesions. Changes were more marked in the more proximal area.
On the contrary, only three cases classified in Stage X presented homogeneous shadows ex-
tending to the peripheral visceral pleura with lesional lung volume.
Lesions at various stages were found in many segments in each case and in 18 cases bi-
laterally; 22 out of 23 cases disclosed lesions in the lower lobe, but about halfthe cases did not
show lesions in the upper lobe.
The M. pneumoniae serum antibody titer did not show the correlation with the number of
segments involved.
Conclusion (Fig. 2):
1. The lesions ofM. pneumoniae infection ofthe lung were roentgenologically started in the
peribronchial and periarterial interstitium in roentgenologically observable order-Stage I.





Acute phase Recovery phase Stage I
FIG. 1. Scheme 1.
FIG. 2. Scheme 2: normal alveolar septa,
alveolitis, intraalveolar exudate.
8703. Therefore, in Stage I and Stage II, the peripheral subpleural region tended to be free of le-
sions.
4. With the increase in interstitial tissue reaction, an alveolar exudate was finally pro-
duced-Stage III.
5. Characteristically, the changes in Stage I did not present obvious abnormal densities in
routine posteroanterior radiographs, but could be detected as obscured pulmonary arterial
silhouettes.
6. Three cases disclosed homogeneous and relatively high density shadows reaching the
peripheral visceral pleura with diminished lesional lung volume-Stage X.
7. The distribution of lesions tended to be bilateral and in many segments.
8. No relation was found between the M. pneumoniae serum antibody titer and the number
of segments involved.
Pleuropneumonia Due to Mycoplasmapneumoniae. Yoko Nagayama. Chiba Uni-
versity School of Medicine, Chiba-shi, Japan; Nobukiyo Sakurai. Asahi General
Hospital, Asahi-shi, Chiba, Japan; and Tomomichi Kurosaki. Chiba University
School of Medicine, Chiba-shi, Japan
Pleural effusion was observed in 42 of 421 cases of pneumonia due to Mycoplasma pneu-
moniae (M.P.) confirmed culturally and/or serologically, and M.P. was cultured from pleural
effusion in two of these patients.
One is an 11-year-old girl. Her illness started with fever, cough, sore throat, headache, and
hyperemia of conjunctivae.
On admission, as the chest X-ray indicated a suspicion of pleural effusion, a diagnostic
thoracocentesis was done and 30 ml of clear yellow fluid was obtained. The specimen con-
tained 4 g/dl of total protein, lymphocytes, histiocytes, and activated mesothelial cells. She
was treated only with erythromycin orally. The IHA antibody titer of pleural fluid (2,560-fold)
was higher than that of the serum (640-fold), but the CF antibody of the same specimens
showed opposite results. That of the pleural fluid was 64, and that of the serum was 128.
The other case was a seven-year-old boy. His illness started with fever and cough followed by
exanthema, hyperemia of conjunctivae, and liver enlargement.
Thoracocentesis on the fourth hospital day yielded massive pleural fluid; the total amount of
specimen taken in two extractions was 200 cc, having a specific gravity of 1.028 and a total pro-
tein of 2.9 g/dl.
He was treated with penicillin but without effect. His total febrile days were 17 days. The
IHA and CF antibody titers of pleural fluid were lower than that of the serum.
We tried to culture M.P. from the pleural fluid in eight cases but failed in all except two
cases.
Many complications and clinical characteristics were observed in the pleuropneumonia
cases, and were summarized as follows:
1. Incidence of fever was high and febrile duration was long.
2. Serum antibody titers for Mycoplasmapneumoniae generally reached high levels.
3. Infectious signs in laboratory examinations were strong and eosinophilia in peripheral
blood was observed.
4. Exanthema, liver dysfunction, and hyperemia of conjunctivae were observed with
high frequency.
Clinical Studies on Pneumonia Caused by Mycoplasmapneumoniae. M. Obana, Y.
Kobayashi, I. Fujimori. Kawasaki Municipal Hospital, Kanagawa, Japan
The clinical features in 43 patients withpneumonia caused byMycoplasmapneumoniae were
studied. The diagnosis was based on the elevation of the titer of CF test for M. pneumoniae.
Elevation of GOT and/or GPT was observed in about 40 percent of patients, as shown in
Fig. 1. Tendency to longer persistence of abnormal GPT value than that ofabnormal GOT
value was noted, as shown in Fig. 2.
A positive correlation between the titer of CF test on admissionandthe days fromonsetun-
til resolution of fever was clarified in this study as shown in Fig. 3.
























FIG. 1. Laboratory data
on admission: Values of
GOT and/or GPT elevated




FIG. 2. Serial changes ofGOT
and GPT in patients with pneu-
monia caused by M. pneumoniae:
Elevation of GOT was normal-







FIG. 3. Relationship between the
titer of CF test for M. pneumoniae on
admission and the days from onset un-
til resolution of fever: A positive cor-
relation was significant (p < 0.01).
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-A Case of Mycoplasmapneumoniae Pneumonia Associated with Meningoencepha-
litis. K. Suzuki, S. Matsubara, M. Uchikata, H. Tanabe, H. Okano, H. Tanimoto,
H. Matsuoka. Toranomon Hospital, Toranomon, Minatoku, Tokyo, Japan
A 18-year-old female was admitted to our hospital on October 2, 1980, because of fever,
headache, and disturbance of consciousness. On admission she was stuporous, and had slight
neck stiffness and positive Kernig's sign. Her temperature was 36.7°C, pulse 96 beats/minute,
and blood pressure 110/60 mmHg. Dry rales were heard over both lungs. A chest X-ray
showed diffuse homogeneous shadows in the left mid-lower lung fields (Fig. 1). Laboratory
data were the following: ESR 75 mm/hour, CRP +, WBC 7,400/mm3, cold agglutinin titer
>2,048, M. pneumoniae complement-fixing (CF) titer 512. The cerebrospinal fluid (CSF)
findings are shown in Table 1. The cultures of the CSF yielded no bacteria and viruses.
She was treated with 8 mg of ,3-methazone, 120 mg of gentamicin, and 100 mg of minocy-
cline daily. Such a combined therapy was continued for about three weeks. It was lowered
gradually along with her complete recovery from the disease (Fig. 2). An attempt to isolate M.
pneumoniae from the CSF was successful on the forty-sixth day from the onset of her illness.
We obtained direct evidence of invasion by M. pneumoniae of her central nervous system.
TABLE 1
CSF Findings
29/IX 2/X 13/X 20/X 27/X 4/XI 17/XI
Day of illness (10) (13) (24) (31) (38) (46) (59)
Pressure (mmH2O) 220 100 180 205 220 180 160
Cell counts 19/3 44/3 12/3 23/3 16/3 15/3 6/3
Seg. 2 0 1 2 2 4 0
Lymph. 17 22 10 17 11 10 6
Others 0 22 1 4 3 1 0
Protein (mg/dl) 63 31 31 35 40 41
Glucose (mg/dl) 66 52 53 38 50 49 48
Cl (mEq/l) 118 117 124 122
M. pneumoniae CF x2
Bacteria (-) (-) (-)
Tubercle bacillus (-) (-) (-)
Virus (-)
M. pneumoniae (+)
FIG. 1. Chest X-ray film on admission.
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FIG. 2. Clinical course.
Clinical Complications of Mycoplasmapneumoniae Infections in an Epidemic. K.
Yokota, S. Kanematsu, A. Ishizaki, M. Yoshioka, M. Yayoshi, M. Araake. Tokyo
Women's Medical College, Tokyo, Japan
An epidemic of Mycoplasma pneumoniae infection occurred from 1979 to 1981 in Japan.
During the 19 months of this period, 79 cases of the infection were seen in our clinic. A ma-
jority of these cases appeared in both autumn and winter, with a small peak in March, and a
TABLE 1




No. Symptoms and Complications of cases %
1 Fever 36 94.7
2 Cough 36 94.7
3 Sputum 8 21.1
4 Rales 26 68.4
5 Sore throat 6 15.8
Complications
6 Abdominal pain 8 21.1
7 Diarrhea 5 13.2
8 Headache 6 15.8
9 Vomiting 9 23.7
10 Exanthema 3 7.9
11 Pleurisy unilateral 5 13.2
12 Neurological symptoms 4 10.5
13 Allergic purpura 1 2.6
14 Disturbance of liver function 10 26.3
15 Otitis media 1 2.6
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TABLE 2
Clinical Findings and Culture Results in the Three
Severe Cases of Mycoplasma pneumoniae Infection
Casel:9y male Case2:5y female Case3:15m male
Findings Pneumonia (bil.) Pneumonia (bil.) Pneumonia (bil.)








Diarrhea Abdominal pain Disturbance of liver
Headache function
Complications Neck stiffness




bil.: bilateral r.: right nd: not done
few cases in other seasons. Most patients were of school age, but fairly large numbers of chil-
dren were under school age, on the order of three, five, and four years old. Eight cases were
found under two years of age. The patients manifested various clinical complications, such as
disturbance of liver function (ten cases)-that was the highest number, pleurisy (six cases),
neurological symptoms (four cases), exanthema (three cases), otitis media (one case), and
hematuria (one case).
The severe cases accompanied by observed complications were as follows:
A nine-year-old boy complained of generalized weakness, lethargy and developed
tachypnea, grunting, and nasal flaring. We saw cyanosis on his face, hands, and feet, and
miliary exanthema on his whole body. Weak vesicular sounds with small rales all over his chest
were audible. Chest X-ray showed diffuse infiltrations over bilateral lung fields. Mycoplasma
pneumoniae was isolated from the pharyngeal swab. Antibody titers up to 4,096 x in CF,
40,960 x in PHA, and 1,024 x in CA tests were estimated in serological examinations. On the
twelfth day of illness, headache, pain in lower extremities, and neck stiffness appeared, and
CSF revealed albuminocytologic dissociation. Antibody titers were up to 16 x in CF and 160
x in PHA tests. These signs indicated polyradiculoneuritis. Liver function tests showed mild
abnormalities.
A five-year-old girl suddenly developed a fever of40°C. General weakness, lethargy, severe
cough, tachypnea, nasal flaring, and retraction of intercostal space were also noticed. Chest
X-ray showed the bilateral findings of pneumonia and pleurisy withl massive transudate, in
which cultivation failed to find any microorganism. Mycoplasma pneumoniae was detected
from a blood culture.
A fifteen-month-old boy with Down syndrome developed dyspnea, fever, and disturbance of
liver functions. On thetwenty-third day ofillness, chest X-ray demonstrated apneumatocele at
the lower part of the right lung. Mycoplasma pneumoniae was isolated from the pharyngeal
swab.
An 18-year-old female had relapsed three times during 15 months. Every time the titers of
CF and PHA had elevated, and chest X-ray had shown the infiltration at the lower part of the
right lung. Immune complex slightly increased to 5.7Ag/ml at the third relapse ofinfection and
decreased to 2.3 Ag/ml six months later.
Three cases of familial infection were observed and consisted of the six patients who had
various latent periods, symptoms, and severities, including the severe illness of a seven-month-POSTER SESSIONS
old male infant. The fact suggests that infants could suffer from severe infection by exposure
inconsistently to Mycoplasma pneumoniae in a situation such as familial infection.
Mycoplasma pneumoniae infection in children had long been considered to be a mild and
self-limiting disease. However, as mentioned above, severe cases with various types of com-
plications are not rare. Particular attention should be paid to the possibility of severe effects.
Mycoplasma pneumoniae Infections with Cardiac Involvements. Nobukiyo
Sakurai. Asahi General Hospital, Asahi-shi, Japan Yoko Nagayama. Chiba Uni-
versity School of Medicine, Chiba-shi, Chiba, Japan
Cardiac involvements of Mycoplasma pneumoniae (M.P.) infection were observed among
571 children with such infections. Age distribution was: one one-year-old, one two-year-old,
one three-year-old, three four-year-olds. Sex distribution was three boys and three girls. The
procedures of diagnosis of their M.P. infection were cultural and serological techniiques.
Case I was a very rare case of mycoplasmal cardiac involvement withl Stevens-Jolhnisoni syni-
drome. He was diagnosed by both M.P. culture from his ulcerative oral cavity and the eleva-
tion of CF antibody. He showed severe cardiac manifestations.
Case 2 was the only case who died, eight months after first admission, and during hler first
admission with severe cardiac manifestation. Anemia of unknown origin was observed; this
finding suggested to us the possibility ofpulmonary bleeding rather than the hemolytic anemia
that is sometimes observed in severe M.P. infections.
Case 3 was a pleuropneumonia case due to Mycobacterium tuberculosis. Her only cardiac
manifestation was arrhythmia. The procedure of diagnosis of M.P. infectioll was only the cul-
ture of M.P.
Cases 4 and 5 were mild cardiac manifestations witlhout cardiac failure.
Case 6 was the most severe case during the acute stage. The cardiac failure was severe and
left a serious sequela.
Table 1
Cardiac involvements of Mycoplasma pneumoniae infections
Case No.
1 2 3 4 5 6
Age (year) 4 2 3 1 4 4
Sex Male Female Female Male Female Male
Procedure of
diagnosis
Culture + ND + ND - ND
IHA - + - + - +
CF + ND - + + +
pleuro pleuro
Pneumonia - - pneu- pneu-
monia monia
Fever + + + + + +
Exanthema + - + + +
Cardiac failure
Cardiac enlargement +
Arrhythmia + - + - - +
Gallop rhythm + + - + + +
Electrocardiogram
Low voltage + + - + 4 +
ST-T abnormalities + + - + - +
Elevation of enzyme + + - + + +
Cardiac sequela - + - - - +
876Experimental Mycoplasma pneumoniae Infection in Adult, Suckling, and Cy-
clophosphamide-Treated Mice. S. Ogata, M. Kanamori, T. Katsura, H. Kobayashi,
0. Kitamoto. Kyorin University School of Medicine, Mitaka Tokyo, Japan
The mechanism of the neurologic disease associated with Mycoplasma pneumoniae is
unknown. The present study was undertaken to examine the abilityoftheorganism to enter the
brain of experimental animals. Adult and suckling mice were challenged with the organism by
various routes. In addition, cyclophosphamide-treated mice were infected with M. pneumoniae
to examine the susceptibility of compromised hosts to the infection.
Recovery ofM. pneumoniaefrom lungs, brains and bloodafter aerosol or intranasal instil-
lation: SPF ICR mice, four weeks old, were infected with 10' colony-forming units of M.
pneumoniae strain 104166 by intranasal instillation. The mycoplasma was isolated from lungs
and brains six days after the infection. One-day-old suckling ICR mice were infected with the
mycoplasma by exposure to the aerosol. On day 12 after the exposure, the organisms were
isolated from the lungs and brains of the suckling mice. The susceptibility ofsuckling mice to
M. pneumoniae was much higher than that of adults. The mycoplasma was not detected in the
blood of both the adult and suckling mice at any time of autopsy.
Recovery ofM. pneumoniaefrom brains and lungs after intracerebral inoculation: Three-
week-old and one-day-old mice were infected with 2 x 10' CFU of M. pneumoniae by in-
tracerebral inoculation. In suckling mice, the numbers of mycoplasma in the brains decreased
in the early stage after infection, then increased on day 20, and levels of the order of 103-104
CFU per brain persisted over two months. The recovery from adult mice was much lower than
that from suckling mice. The mycoplasma was not isolated from anylung ofeither thesuckling
or adult mice.
Treatment with cyclophosphamide (CY): Adult mice weresubjected to treatment with CY to
determine if such treatment led to systemic infection. Severe leukopenia was caused by the
treatment. In such mice, M. pneumoniae was found not only in the lung but also in the brain,
spleen, and blood after intravenous infection. Persistence of higher levels of the mycoplasma
was noted in those organs during the three-day observation period. On the other hand, in.un-
treated mice, the mycoplasma disappeared rapidly from blood and other organs.
M. pneumoniae was not isolated from any of the specimens of control animals given sterile
broth medium throughout these experiments.
Finally, our results suggest that M. pneumoniae may be able to reach the brain via the blood
and it may occur with relative ease in compromised hosts. However, it seems difficult for the
mycoplasma to enter the parenchyma of brain of normal hosts, because the isolation rate and
titers of M. pneumoniae from brain was low throughout our experiments except in intracere-
bral infection.
We have no evidence that the organism passes the blood-brain barrier and enters the pa-
renchyma of brain. If injury to the blood-brain barrier is produced by a cause such as
metabolic disorder, mixed infection, or an unknown factor, M. pneumoniae will be able to
enter the parenchyma of brain and to grow there.
Electron Microscopic Examination of Human Fallopian Tube and Infected Urea-
plasma urealyticum. Y. Shigeko, Y. Morimasa. Tokyo Women's Medical College,
Tokyo, Japan
Ureaplasma urealyticum might play an important role in humanreproductive failure and in-
fectious diseases of the urogenital tract, because these organismus have often been isolated
from the cervical mucus obtained from patients with unexplained infertility and spontaneous
abortion. U. urealyticum was also isolated from the cervical mucus, lochia ofpuerperal fever
or salpingitis, and pelvic inflammatory disease. However, thepathogenicity of U. urealyticum
has not yet been clearly established. In this study, the organ cultures ofnormal tissues were ex-
perimentally inoculated with U. urealyticum and the cilial activity of the tubal epithelium was
observed microscopically. Also, the uterine and tubal tissues obtained fromsurgicalspecimens
and those experimentally infected were observed under an electron microscope.
Material and Methods: Tubal specimens: Fallopian tubes were surgically removed in these
cases: myoma uteri, tubal plasty, ectopic pregnancy, and other laparotomies. All the patients
were 21 to 54 years in age and were still menstruating.
Tissue culture: In order to examine mycoplasmas inoculated in the tubalepithelium in tissue
877 POSTER SESSIONSculture, approximately 104_-10 colony-forming units of ureaplasmas (B-8) or M. hominis
(type 1) were mixed with Eagle's balanced salt solution and incubated at 37°C and were then
observed every day at the same time for cilial activity. The culture medium, methods, and elec-
tron microscopic methods were routine.
Results: (1) Incidence of U. urealyticum isolation from the reproductive tract: 32.8 per-
cent from the cervical canal, 28.5 percent from the uterine cavity, 21.2 percent and 18.2 per-
cent from the bilateral tubes. (2) Duration of cilial activity of fallopian tubes experimentally
infected with U. urealyticum and M. hominis in tissue culture preservation: The cilial activity
of fallopian tubes experimentally infected with U. urealyticum was shorter in duration than
that infected with M. hominis. (3) Electron micrograph of fallopian tube epithelium main-
tained as tissue culture: (a) Experimental tissue culture infected by U. urealyticum: Many spots
had irregular and abnormal epithelial surfaces. Although ciliated cells were present, the cilia
were degenerative and often aggregated. The individual cilium varied in length and in
diameter. An enlarged micrograph shows the spherical particles and filaments observed in the
cilia. (b) Experimental tissue culture infected by M. hominis: Secretory cells show deformation
but predominant cells have microvilli. An enlarged electron micrograph ofcilial cells shows in-
terspersed colonization oftheseorganisms on ciliated cells. (c) Naturally infectedtissuewith U.
urealyticum: The tubal epithelium shows interspersed secreting cells without villi, and the col-
onization of cilial cells shows on an enlarged micrograph. This observation was similar in the
cases experimentally infected with U. urealyticum.
Conclusion: The ciliostatic effects of U. urealyticum was higher than M. hominis and the
uninoculated control. Under electron microscopic examination, the ciliated tubal epithelial
cells were irregular and degenerating. This would suggest that U. urealyticum is more con-
cerned than M. hominis with female infertility with a tubal factor.
Cytological Analysis of Leukocytes in Urine After Prostatic Massage in Urea-
plasma-Associated Prostatitis. W. Weidner. Urologische Klinik Giessen; H. Brun-
ner. Institut fur Chemotherapie, Bayer AG Wuppertal; H. Ebner. Zentrum fur
Pathologie Giessen; H.-G. Schiefer. Institut fur Medizinische Mikrobiologie
Giessen; and H. Krauss. Institut fur Hygiene und Infektionskrankheiten der Tiere
Giessen, Federal Republic of Germany
Ureaplasma urealyticum can be isolated from prostatic secretions of patients with pros-
tatitis. Using the localization technique of Meares and Stamey, the detection of 2104 CFU of
U. urealyticum per ml of EPS and/or 2103 CFU/ml of VB3 together with < 103 CFU/ml of
VBl and VB2 are in our opinion evidence for ureaplasma-associated prostatitis.
"Abacterial" prostatitis is defined as an inflammatory process ofthe prostate as indicated by
high leukocyte numbers in prostatic secretions without infection by conventional microbes as,
e.g., enterobacteriaceae. In this report we present recently obtained data on the number of
leukocytes (PML) in prostatic secretions of patients suffering from ureaplasma-associated
prostatitis.
The results are shown in Table 1. In healthy controls no borderline or pathological numbers
ofPML were demonstrable. In 105 of 142 men suffering from symptoms ofprostatitis but with
negative microscopy ofculture for microorganisms, normal numbers of PML were seen. Elev-
en of 17 borderline values and 17 of 20 pathological numbers could be explained as persisting
symptoms of previous urethritis or evidence of heavy inflammatory reactions of the "urethra
posterior" by X-ray study of urethroscopy. In 17 of 43 patients with C. trachomatis isolated
from a urethral swab after P.M., significant numbers of leukocytes were not detectable. In
contrast, all men with prostatitis due to T. vaginalis (2x), M. tuberculosis (2x), or chronic
bacterial prostatitis caused by enterobacteriaceae or enterococci showed significantly high
numbers of PML. Similarly high numbers of PML were evident in the 18 patients with
ureaplasma-associated prostatitis. This was also the case in fourpatients with double infections
of U. urealyticum and C. trachomatis.
Conclusion: In patients with ureaplasma-associated prostatitis the number of PML in pros-
tatic secretions is elevated as compared to healthy controls. The leukocyte pattern is in ac-
cordance with chronic bacterial prostatitis due to common bacteria. The data provide evidence
for an inflammatory reaction of the prostate in the cases mentioned.
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879Isolations of Ureaplasma urealyticum from Japanese Patients with Nongonococcal
Urethritis. N. Katoh, Y. Shimizu, Y. Kawada, T. Nishiura. Gifu University School
of Medicine, Gifu-City, Japan
Patients with four or more polymorphonuclear cells (PMN) per high-power field (hpf) in
urethral discharge and with some urethral symptoms, but without gonococcus, were regarded
as NGU (82 cases). Control groups consisted of 79 males with gonococcal urethritis (GU) and
males without urethritis (26 cases), respectively. Specimens to be examined were obtained by a
swabbing technique and cultivated quantitatively by serial tenfold dilution in T-broth.
U. urealyticum was isolated with a frequency of 52 percent in NGU, 56 percent in GU, and
42 percent in healthy subjects without urethritis. U. urealyticum was isolated from 64 percent
of 22 patients in NGU group B, of which no bacteria was found in specimens by microscopic
examination. 105 or more CCU/ml of U. urealyticum appeared more frequently in NGU than
in healthy subjects, but not in GU. The difference was more apparent when NGU group B was
compared with healthy subjects. The relation between CCU counts of U. urealyticum and
PMN counts in urethral discharge was not uniform. In specimens with low PMN counts
(c3/hpf) U. urealyticum was never found in high numbers (> 10'/ml). The most specimens
from NGU with CCU counts of 105 or more per milliliter were obtained from those with PMN
counts between 4 and 29, in contrast with GU in which 90 percent of the patients had PMN
counts of + + or more in specimens. Some of the NGU patients harboring U. urealyticum
were treated with doxycycline (four cases), minocycline (two cases), co-trimoxazole (six cases),
ampicillin (one case), and cephalexin (two cases). Doxycycline and minocycline, which are ac-
tive in vitro against U. urealyticum, were effective in NGU; all ofthepatients treated withthese
antibiotics showed neither urethral symptoms nor more than four PMN in specimens after the
treatment.
Three of these patients had U. urealyticum with CCU counts of 10' or more per milliliter
before the treatment and none of U. urealyticum after the treatment. However, in a patient
treated with doxycycline, U. urealyticum was not eliminated (103- 103/ml) in spite ofimprov-
ing urethral symptoms and removal of PMN. Patients treated with co-trimoxazole which is not
active in vitro against U. urealyticum had decreasing CCU counts of U. urealyticum (less than
104/ml) with improved urethral symptoms and PMN after the treatment. U. urealyticum,
PMN, or urethral symptoms could not be removed in a patient by ampicillin treatment.
In conclusion, statistically significant differences in the rate of isolation of U. urealyticum
among NGU, GU, and healthy subjects could not be found even if NGU group B was com-
pared with healthy subjects. However, increasing the number of NGU group B would sup-
posedly cause a significant difference in the rate of isolation of U. urealyticum between NGU
and healthy subjects. CCU counts of 10' or more per milliliter of U. urealyticum appeared
much more frequently in NGU than in healthy subjects. In specimens with low PMN counts
TABLE 1
Quantitative Count of U. urealyticum in Specimens
from Patients with NGU and GU, and Males without Urethritis
Color-Changing Unit (CCU)/ml
Total
10 102 103 104 >.10 No.
(A) 8 7 13 6 9 43
NGU (19) (16) (30) (14) (21)
(1O) B 1 2 5 1 5 14
(B) (7) (14) (36) (7) (36)
GU 10 12 3 9 10 44
(%0) (23) (27) (7) (20) (23)
Healthy 2 2 4 2 1 11
(o) (18) (18) (36) (18) (9)
(A), All of NGU patients
(B), Patients without bacteria in specimens by microscopic examina-
tion
880 POSTER SESSIONStaken from outpatients complaining of urethral symptoms U. urealyticum was never found in
high numbers (> 105/ml). These results and the chemotherapeutic results in NGU would sug-
gest that CCU counts of at least 105 or more per milliliter would be a reasonable pathogenic
count for U. urealyticum according to our method. It is suggested that there is a possibility that
some of the patients with GU would also be infected concomitantly by U. urealyticum.
Isolation of Ureaplasma urealyticum and Mycoplasma hominis from Amniotic
Fluid at 16 to 20 Weeks of Gestation: Potential Effect on Outcome of Pregnancy.
M.B. Brown, G.H. Cassell, R. Davis, P.M. Marriott, K.B. Waites, N.C. Cox, S.
Stagno. University of Alabama, Birmingham, AL
Sixty-five amniotic fluids collected at the time of amniocentesis (16-20 weeks' gestation) for
TABLE 1
Pregnancy Outcome for Women Whose Amniotic Fluids Were Cultured at
Amniocentesis (16-20 Weeks' Gestation)
Of 30 Total Dark Fluids
Total Cloudy Dark U. urea- M. homi- Myco-
Fluids Clear Yellow Fluids lyticum nis plasma
Cultured Fluids Fluids (Total) Positive Positive Negative
No. fluids
cultured 65 27 8 30 2a 2a 26
Mean gest.
age (wks) 38 39 38 38 26 38 39
Mean birth
wt. (g) 3,130 3,119 3,198 3,027 757 2,276 3,279
No. term
births
(.37 wk) (N) 54(83) 23(85) 7(88) 24(80) 0 1(50) 23(89)
No. premature
births (24-36
wk) (%0) 10(15) 4(15) 1(13) 5(17) 1(50) 1(50) 3(12)
No. spont.
abortions 1 0 0 1 0b 0 O
No. neonatal
deaths 3 0 lC 2 Id 0 le
aRepresents 7 percent of total dark fluids cultured and 3 percent of all fluids cul-
tured.
bPrevious maternal history of six unexplained spontaneous abortions. During cur-
rent pregnancy U. urealyticum isolated at 16 weeks at which time large number of
polymorphonuclear leukocytes present in the fluid, but fetus was healthy and of nor-
mal gestational size as determined by sonography. Amnion cells not cultivable.
Therefore, amniocentesis repeated at 20 weeks, U. urealyticum again isolated, but
sonogram and karyotype normal. At 23 weeks, "break through" bleeding occurred
and retarded fetal development noted upon sonography. At 24 weeks, 463 g fetus
delivered, but died within 24 hours. U. urealyticum isolated from fetal lung, liver,
kidney, spleen, and gall bladder. Routine cultures for bacteria, chlamydiae, and
viruses negative. Extensive inflammation in placenta and lungs. Organisms detected
in areas of inflammation by immunofluorescence.
c24-week infant with placenta previa centralis hemorrhagica.
dU. urealyticum isolated at 20-week amniocentesis. At 26 weeks membranes rup-
tured. Patient treated with 500 mg q.i.d. erythromycin. At 29 weeks a 1,050 g infant
was delivered. Placenta positive for U. urealyticum, but negative for other microbial
agents. Infant nasopharynx and urine positive for U. urealyticum. Blood and other
cultures negative for all other pathogens. Respiratory distress and renal complica-
tions. Died day 21 postnatal life. Cultural results and cause of death not yet deter-
mined.
e26-week infant with cord prolapse.
881 POSTER SESSIONSprenatal diagnosis were cultured for mycoplasmas, chlamydiae, viruses, and bacteria. Fetal
membranes were intact in all cases. Fluids were classified on the basis of color and turbidity
and were divided into three groups: (1) clear and straw-colored, (2) cloudy or yellow, (3) dark
(reddish green to brown). Although the cervicovaginal isolation rate of mycoplasmas (60-70
percent) did not differ among groups, mycoplasmas were isolated only from dark fluids (4/30).
With the exception of Serratia marcescens which was isolated from one cloudy, yellow fluid,
no other microbial agents were isolated. Pregnancy outcome is summarized in Table I below.
The data indicate that: (1) genital mycoplasmas can colonize amniotic fluid early in pregnancy
even when fetal membranes are intact; (2) only a subgroup of females colonized in the lower
genitourinary tract are colonized in the amnionic sac. For undetermined reasons women with
dark fluids are at greatest risk; (3) fetal death does not necessarily precede mycoplasmal in-
vasion ofthe fetus; and, finally, (4) mycoplasmal, particularly ureaplasmal, amniotic infection
may have an adverse effect not only on prenatal diagnosis, but also upon the outcome of preg-
nancy.
A Method for Evaluating the Therapeutic Effect of Antibiotics on Mycoplasma In-
fectious Diseases. T. Kanemitsu, R. Yamashita, K. Sunakawa, T. Sugiyama. School
of Medicine, Keio University, Tokyo, Japan; N. Yamashita, T. Azuma. Kitasato
Institute Hospital, Tokyo; and Y. Ichihashi. School of Medicine, Keio University,
Tokyo, Japan
Macrolides have been used as the first choice of chemotherapy for human mycoplasma in-
fectious diseases because of the lower minimum inhibitory concentration (MIC) for myco-
plasmas in vitro and the most effective antibiotics clinically. However, a way of evaluating
clinical effects has been requested, as macrolide-resistant strains were reported recently. This
evaluation should confirm that the chemical dose of the antibiotics in the circulating blood of
patients after administration of drugs was parallel or not to the inhibitory effect against the
mycoplasmas. Several antibiotics were assessed for examination in vitro incubating with myco-
plasmas in twofold dilution series of culture medium and patients' serum one to three hours
after administration of antibiotics orally or intravenously.
Material and Method: Specimens: M. pneumoniae standard strain FH, MAC, and frozen
(- 80°C) wild strains isolated from ten patients were investigated. Media: The broth media
contained 7 parts PPLO broth base (Difco Laboratories, Detroit, MI), 1.5 parts horse serum
(Kitasato Institute Laboratories, Tokyo), I part fresh yeast extract, and 500 units of penicillin
G/ml (final concentration). Phenol red (final concentration, 0.002 percent) and glucose (final
concentration, 0.5 percent) were added. Blood Samples: Blood samples were collected from
patients given antibiotics by oral or intravenous drip infusion. All sera were investigated by the
complement fixation test for mycoplasma and the concentration of antibiotics determined by
bioassay method. Method: A sample of the specimen (0.1 ml) and of the serum (0.2 ml) were
inoculated into a broth, then diluted by twofold series and incubated at36°C. M. pneumoniae
growth was indicated by a color change in the medium due to acid production. Inoculated
broths were observed for 7-10 days. At the time a control broth without serum changed to
yellow, each broth was confirmed for M. pneumoniae growth or not.
Result: MIC of the standard strain FH was 0.025Ag/ml. The influence for growth inhibition
against M. pneumoniae FH by erythromycin concentration in sera inactivated or not is shown
in Table 1. Each complement fixing antibody titer for M. pneumoniae in sera showed <1:4.
Sera showing higher concentration level than MIC inhibited growth ofM. pneumoniae whether
inactivated or not. Lower concentrations did not inhibit growth. However, the one which
showed a similar concentration level to MIC suggested a difference between inactivated serum
or non-inactivated serum. M. pneumoniae growth inhibition by the same patient's serum col-
lected before and after administration of erythromycin, inactivated and not inactivated, is
shown in Table 2. The serum after administration of erythromycin inhibited growth whether
inactivated or not; however, serum before administration of erythromycin showed the dif-
ference between inactivated serum or not inactivated serum. MIC of M. pneumoniae wild
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TABLE 2
Comparison with the Serum of Patients Inactivated and Not Inactivated,
Before and After Administration of Erythromycin
Serum: Broth Serum: Broth Serum: Broth
1:10 Dilution 1:20 Dilution 1:40 Dilution
22 hours after administration Inactivation (-) (-) (-)
of erythromycin by continuous
intravenous drip infusion Non-
(27 mg/Kg) inactivation (-) (-) (-)
Inactivation (+) (+) (+)
Non-administration
Non-
inactivation (-) (-) (+)
(+) growth
(-) non growth
strains isolated from ten patients for erythromycin showed a higher level than that of standard
strain FH. Moreover, each strain which added sera collected from four patients given
erythromycin orally and not inactivated, was incubated. Consequently, the serum contained
higher concentration of erythromycin (one case only) than each MIC inhibited growth, but
lower ones yielded various effects because of unheated sera.
Discussion: MIC of erythromycin in the patients' inactivated serum for M. pneumoniae was
parallel to the MIC in liquid culture medium in vitro. However, the effect ofgrowth inhibition
oferythromycin examined in the patients' serum was better than in the culture medium in vitro.
MIC oferythromycin in patients' serum forM. pneumoniae isolated from patients (wild strain)
was higher than standard strains (MAC and FH). Now, we are investigating the problem ofthe
growth inhibition effect of serum itself and the effect of many kinds of antibiotics.
Characterization of Tetracycline-Resistant Strains of Ureaplasma urealytict
Isolated from Humans. Janet A. Robertson, Ming H. Chen, Gerald W. Stemi
University of Alberta, Edmonton, Alberta, Canada
Ureaplasma urealyticum is one of the etiological agents ofnon-gonococcal urethritis. About
two percent ofwild-type strains have a minimal inhibitory concentration (MIC) oftetracycline
of 128 isg per ml or greater, a concentration that represents functional resistance to the an-
tibiotic. Twenty-five such strains were cloned three times. Three strains lost their high level of
resistance to tetracycline during this procedure. The strains were serotyped by a colony
epifluorescence method. All strains reacted with at least one of the 14 antisera in our sero-
typing scheme. Apart from a strong correlation (chi square test) with type 9, the strains dis-
played diverseantigenic determinants. Offive strains demonstrating with thetype 2 specificity,
none reacted with anti-5 serum. Most other isolates with the type 2 determinant, including our
standards, show extensive 2, 5 cross-reactivity. The response of the 22 tetracycline-resistant





















884There is no apparent correlation between these susceptibility patternsand serotype, except for
tetracycline.
The twenty-five strains were also divided in their response to 1 mM manganiesewhicih sepa-
rates U. urealyticum into two biotypes. This responsehad no apparent correlationi with
serotype or with antimicrobial susceptibility patterns. Serialthin-sectionls were examinied by
electron microscopy. Cells cultivated in antibiotic-free medium were distinct spherical enitities
of uniform morphology, while cells cultivated in sub-inhibitory concenitrationis of tetracyclinie
showed incomplete division and thus presented a beaded appearanice. The broad butthinimem-
branous bridges between such cells often carried a narrower "bleb" structure.
Sensitivity of 71Mycoplasmapneumoniae Strains toVariousAntibiotics. S. Ogawa.
Sapporo Medical College, Sapporo, Japan; M. Umetsu. Hokkaido Children's
Hospital and Medical Center, Sapporo, Japan; and S. Chiba, T. Nakao. Sapporo
Medical College, Sapporo, Japan
The present study was performed in order to examine the yearly change in sensitivity of 71
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FIG. 1. In VitroSensitivity ofClinical Isolates by Isolated Year: Comparison with Standard
Serum and/or Sputum Concentrations of Antibiotics.
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clinical isolates ofMycoplasmapneumoniae to 14 antibiotics from five groups. The antibiotics
tested were erythromycin, midecamycin, leucomycin, josamycin, oleandomycin, spiramycin,
tetracycline, doxycycline, minocycline, chloramphenicol, lincomycin, clindamycin, strepto-
mycin, and dibekacin. The clinical isolates were obtained during the three-year period (from
September 1978 through July 1981). The sensitivity ofthe standard strain, Mac strain, was also
tested. For determination of sensitivity, the agar dilution method was employed, using an agar
medium essentially the same as that described by Chanock and co-workers. The inoculum size
of M. pneumoniae was 10' CFU/ml. The MICs of the respective antibiotics were determined
after seven days of incubation at 37°C.
The results of the study revealed that the sensitivity of the standard strain was in agreement
with those reported by Jao et al. and Niitu et al. Regarding clinical isolates, there was no sig-
nificant yearly change in the sensitivity to all the antibiotics tested. The 71 strains were all very
sensitive to the macrolides, especially erythromycin, followed by midecamycin, josamycin, and
leucomycin (equal rank), at concentrations much lower than the serum levels attained after the
standard oral doses. The sensitivity to tetracyclines and the lincomycin groups was lower than
those to the macrolides. Chloramphenicol showed higher MICs than tetracyclines. The MICs
of streptomycin to all the strains were 0.78 mcg/ml or less. The results with nine antibiotics are
shown in Fig. 1.
Antibiotic Effect ofChlorpromazine on Mycoplasmas. K. Lind, J.E.H. Kristiansen.
Mycoplasma Laboratory and Department of Diagnostic Bacteriology, Statens
Seruminstitut, Copenhagen, Denmark
Chlorpromazine (CPZ) belongs to a group of drugs that are widely used as neuroleptics in
human psychiatry. At the cellular level they act as membrane stabilizers. CPZ and related
drugs also have an antibacterial effect in vitro against a variety of bacteria [1,2].
We investigated the action of CPZ and related drugs on three human species: Mycoplasma
(M.) pneumoniae, M. hominis, and Ureaplasma (U.) urealyticum.
CPZ showed inhibition ofgrowth or killing in vitro of all three species at concentrations be-
tween 156 and 312Ag/ml depending on the inoculum ofmycoplasmas. U. urealyticum was the
most resistant. Enzyme activity of the mycoplasmas (splitting of glucose, arginine, and urea)
was inhibited by between 10 and 100 Ag/ml of CPZ which still allowed multiplication of the
organisms.
While classical antibiotics or specific antibodies under certain conditions may inhibit the
growth of mycoplasmas in vitro without inhibiting enzyme activity [3], the reverse was the ef-
fect with certain concentrations of CPZ.
Another drug, chlopenthixol, has a neuroleptic effect when used in the cis(Z)-clopenthixol
isomer form, while the trans(E)-clopenthixol is without this effect. However, both isomers
show an antibacterial activity in vitro against a variety of bacterial strains 14]. We tested the
stereo-isomers against the three mycoplasma species, and both isomers were inhibiting growth
at concentrations < 100 Ag/ml.
This opens up the prospect of creating new antibiotics with unusual antimicrobial spectra
and activities. The combined use of neuroleptics and classical antibiotics is not uncommon,
and their interactions in vitro and in vivo should be investigated. The phenothiazines might be
useful tools in the study of mycoplasma membranes.
REFERENCES
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4. Kristiansen JEH, Mortensen I: Acta Pathol Microbiol Scand (B) 89:437, 1981Results of Administration of 9,3"-Diacetylmidecamycin as Treatment for Myco-
plasmal Pneumonia. T. Motohiro, K. Ichikawa, F. Yamashita, M. Nakamura.
Kurume University School of Medicine, Kurume, Japan
A derivative of midecamycin (MDM), 9,3"-diacetylmidecamycin (MOM), is a newly
developed macrolide antibiotic. Our research group carried out a comparative study on MOM
dry syrup and erythromycin (EM) dry syrup in the treatment of patients diagnosed as having
mycoplasmal pneumonia. MOM dry syrup was administered to 162 patients ranging in age
from ten months to 16 years and 7 months. EM was administered to 54 patients having a simi-
lar age range.
In the MOM treatment group, the mean daily dosage was 21.8 mg/kg for 100 ofthe 162 pa-
tients; this was given in three divided doses. In 90 percent of these patients, the time of the ad-
ministrations was after meals, and the drug administration route was oral. The mean duration
of the treatment was 12 days. In 36 of the 54 patients in the EM treatment group, the mean
daily dosage was 46.4 mg/kg, given in four divided doses. The administration route was oral in
81.8 percent of the patients, while the mean duration of the EM therapy was 13 days.
Looking at the clinical efficacy of the drug therapies as a function of the daily dosage, we
find that for the 20 mg/kg or less and 21-30 mg/kg MOM dosage group and the 41-50 mg/kg
EM dosage group, the respective clinical efficacy rates on days 3, 7, and 10 of the administra-
tion programs showed no significant differences. An overall rating of the clinical efficacy on
the three evaluation days for each of these groups gave global efficacy rates that also show no
significant differences.
The clinical efficacies of the drug therapies were considered as a function of the duration of
the disease prior to the start of the therapy. It was found that there were no significant dif-
ferences between the MOM treatment subgroups having disease lead times of 4-7 days and
8-14 days, and the EM treatment subgroup having a lead time of 4-7 days when their clinical
efficacy rates for evaluation days 3, 7, and 10 were compared.
For the MOM treatment group, it was possible to evaluate the bacteriological efficacy in 33
patients, and the eradication rate for the M. pneumoniae causative organisms was 65.6 per-
cent. This evaluation was possible for only three patients in the EM treatment group, and the
bacteriological status remained unchanged in two, while the microbe was eradicated in the
third patient. There were no significant differences between the 20 mg/kg or less and 21-30
mg/kg MOM dosage groups and the 51 mg/kg EM dosage group.
The in vitro drug sensitivities of50M. pneumoniae strains were measured, and the results in-
dicated that the MIC distribution of MOM was similar to those of midecamycin and josamy-
cin, but was two levels inferior to the distribution of EM's MICs.
With regard to the side effects of these drug therapies, in the MOM therapy group, diarrhea
occurred at an incidence of 1.2 percent and soft stool at an incidence of0.6 percent. In the EM-
treated patients there were no side effects. None of the patients in either the MOM or the EM
therapy group were found to show any abnormal values in the laboratory tests.
On the basis of these findings, we have concluded that MOM dry syrup, administered orally
to child patients with mycoplasmal pneumonia in a daily dosage of 20 mg/kg as three equal
doses after meals, is capable ofproviding the same clinical efficacy and bacteriological efficacy
as EM dry syrup administered orally in a daily dosage of40-50 mg/kg in four equal doses. We
believe that MOM dry syrup is a useful drug for the treatment of mycoplasmal pneumonia.
Efficacy of RU 28965, a New Macrolide Against Mycoplasma pneumoniae.
M. Komori, M. Sai, A. Ikebe, H. Tomita, Y. Suzuyama, H. Iwasaki, K.
Yamaguchi, K. Izumikawa, A. Saito, K. Hara. Nagasaki University School ofMedi-
cine, Nagasaki, Japan; and H. Kobayashi, 0. Kitamoto. Kyorin University School
of Medicine, Tokyo, Japan
Studies were carried out on RU 28965 (Fig. 1), a new macrolide derivative, to determine its
antimycoplasmic activity against Mycoplasma pneumoniae and its serum level in comparison
with erythromycin (EM), josamycin (JM), and leucomycin (LM).
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RU 28965 was found to be almost equal to EM, JM, and LM in its anti-mycoplasmic sen-
sitivity distribution against clinically isolated strains of M. pneumoniae and also in its anti-
mycoplasmic effect against experimental M. pneumoniae infections in hamsters (Figs. 2, 3).
RU 28965 0.5 g tab. and EM I g tab. were administered orally to men and the serum levels
determined. The peak serum level of RU 28965 was obtained more rapidly and at a peak
several times higher than that ofa double dosage ofEM. Consequently, ahigher serum level of
RU 28965 was maintained for a longer time than that for EM (Fig. 4).
These results have suggested that RU 28965, when administered orally, should be valuable in
clinical use.
Experiences in the Treatment of Mycoplasmal Pneumonia with Josamycin. Ryo
Hakuta, Tatsuya Hayashi, Mariko Fujitsuka, Seiko Ajiro, Yoshitaka Ishida, Mari
Hoshi, Kazunori Matsutani. Matsudo Municipal Hospital, Chiba Prefecture, Japan
Mycoplasmal pneumonia is generally mild and self-limiting, but occasionally extra-
respiratory complications such as pleural effusions, myocarditis, menigoencephalitis, and
renal failure may occur. Since Mycoplasma pneumoniae do not possess cell walls, the peni-
cillins, which are inhibitors of bacterial cell-wall synthesis, are not effective in the treatment of
mycoplasmal infections. Instead the macrolides and tetracyclines, which are potent inhibitors
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FIG. 2. Changes in SGOT, SGPT, and LDH levels before and after treatment with JM-P.
ofprotein synthesis, are used. After treating 20 hospital patients with mycoplasmal pneumonia
using Josamycin propionate(JM-P), a macrolide antibiotic (40 mg/kg/day P.O.), we found
that this anti-microbial agent brought about an improvement in the clinical status in all pa-
tients and at the same time shortened the course of the disease. The patients' ages ranged from
five to 14 years (mean, 7.5 years). Diagnosis was established by typical infiltration or increase
in bronchovascular marking on chest X-ray, and by a rise in specific mycoplasma IHA an-
tibodies. Titers greater than 1:1280 (when a single specimen is obtained) or a fourfold increase
between acute and convalescent sera will be diagnostic. Among the 20 patients 5(25 percent)
had skin eruptions, 2(10 percent) had serous pleural effusions, 1(5 percent) had myocarditis,
1(5 percent) had otitis media complicated by sinusitis, 1(5 percent) had hepatitis, and 6(30 per-
cent) demonstrated mild liver dysfunction. From a clinical standpoint JM-P was judged to be
markedly effective in four patients and moderately effective in the remaining 16 patients. One
case, a seven-year-old boy, was complicated by myocarditis and pleural effusion. ECGrevealed
a second degree A-V block of the Wenckebach variety. Treatment with JM-P resulted in a
dramatic improvement in clinical status (Fig. 1). The macrolides are known to cause side ef-
fects such as gastrointestinal symptoms and liver dysfunction. We experienced no such adverse
effects with JM-P. JM-P is an effective agent in the treatment of mycoplasmal pneumonia even
in patients with hepatitis or liver dysfunction (Fig. 2).
Comparative Study of Effectiveness of 9,3"-Diacetylmidecamycin (MOM) and
Midecamycin on Respiratory Tract Infections. H. Tomita, M. Sai, M. Komori, Y.
Suzuyama, H. Iwasaki, A. Ikebe, K. Izumikawa, A. Saito, K. Hara. Nagasaki
University School of Medicine and 16 Related Hospitals, Nagasaki, Japan
The drug efficacies of midecamycin (MDM) and its new derivative, MOM, were compared
by means ofa double-blind study. A total of218 patients were diagnosed as having pneumonia
on the basis of chest X-rays. They were treated orally for 14 days with MOM in a daily dosage
of600 mg, or MDM in a dosage of 1,200 mg/day. The therapeutic efficacy rates against these
pneumonia patients were 86.3 percent with MOM and 92.9 percent with MDM. Accordingly,
in both of these drug administration groups the efficacy rate was high, and no statistically
significant difference existed between them.
The minimal inhibitory activities (MIC) of MOM, erythromycin (EM), josamycin (JM), and
MDM against Mycoplasma pneumoniae strains were compared. MOM showed inhibitory ac-
tivity at a concentration of0.0313 mcg/ml. The anti-mycoplasmal activity of MOM was some-
what inferior to that of EM, but MOM was concluded to be a drug having superior activity
compared with JM and MDM.
890 POSTER SESSIONSMOM and MDM showed no differonces with regard to the improvement in the disease symp-
toms and findings. Only a few side effects developed to the drugs, and all of them improved
immediately once the drug administrations were stopped.
It was concluded that MOM provides almost the same therapeutic efficacy as MDM even at
half the dosage, and that this is an effective drug for use in the treatment of infections of the
respiratory organs.
Utility of Hen's Egg Yolk as a Substitute for Horse Serum in the Growth Medium
for Mycoplasmas. T. Sasaki, M. Shintani, F. Kameoka, K. Kihara. National Insti-
tute of Health, Tokyo, Japan
Hen's egg yolk was suspended in sterile phosphate-buffered saline at a concentration of 20
percent (w/v), and the suspension was centrifuged at 15,000 g for 40 minutes. Penicillin G was
added to the supernatant to become 500 IU/ml. This supernatant was referred to as "EY" and
stored at 4°C. EY-agar and EY-broth media, supplemented with 10 percent EY, had sufficient
transparency, and showed enough growth-supporting activity, for some mycoplasma strains
equivalent to Chanock's media. M. pneumoniae especially showed a good growth in the EY-
broth medium.
The growth ofM. pneumoniae in four kinds ofbroth media shown in Table I was examined
(Figs. I and 2). EY medium always showed a good growth-supporting activity for both strains
of M. pneumoniae rather than Chanock's medium, and was effective in promoting growth of
small numbers ofM. pneumoniae. These results show that EY-broth medium may be useful as
the isolation medium and the metabolic inhibition test medium for M. pneumoniae in diag-
nosis of M. pneumoniae infection. Moreover, EY was rather superior to horse serum in the
following respects: (1) inexpensive and easy to obtain, (2) preservable at 4°C for two years, (3)
consistent in the growth-supporting activity for mycoplasmas among various EY preparations.
TABLE 1
Test Media Used in the Experiments
Media
Component HS Chanock EY EY+Y.e
0 0 A A
PPLO broth*' 80*3 70 90 80
Yeast ext. - 10 - 10
Horse serum*2 20 20 - -
EY - - 10 10
All media contain glucose 1 percent, phenol red 0.002
percent, and Penicillin G 5001U/ml
*lDifco 671893
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Molecular Identification of Cell Surface Lectins and Glycoproteins in Different
Human Mycoplasma Strains-Their Possible Role in Cell Adhesion. H. Blenk.
Ernst Rodenwaldt Institute, Koblenz, West Germany; R. Arndt. University ofHam-
burg, West Germany; and B. Blenk. Ernst Rodenwaldt Institute, Koblenz, West
Germany
Recently, glyco-conjugates and lectins have been found to exert substantial effects on
cellular recognition and communication at the membrane level between pro- and eucaryotes.
Our investigations centered on the evaluation ofglyco-conjugates and lectins in the cell surface
of M. hominis, U. urealyticum, and M. pneumoniae. 'l25-radioiodination of the living myco-
plasmas was performed by the lactoperoxidase coupling method, followed by solubilization
and binding to different sugars or lectins coupled to sepharose. After this, SDS-Page and auto-
radiography were done.
We could show that M. hominis has at least several glycoproteins (diff. MW) with binding
specificity for Con A, SBA, PNA, and LPA. Beside membrane-lectins with specificity for Lac-
tose (Galactose) (MW 86,000), D-Mannose (MW 113,000) and sialic acid (diff. MW) could be
characterized.
In U. urealyticum we could also identify several glycoproteins with different lectin bindinlg
specificity and different MW. In addition we could show the expression of two groups of lec-
tins in membranes of U. urealyticum with a binding specificity for N-Acetylgalactosamin and
D-Mannose, respectively.
Most of the bindings between membrane proteins and the Sepharose bound sugars or lectins
could be inhibited by the corresponding sugars. The analysis of M. pneumoniae membrane
showed corresponding results. In addition to this we could identify in M. pneumoniae at least
two neuraminic acid binding proteins: one with high MW (-400,000) is composed of several
identical subunits (MW 81,000) linked by disulphide bridges.
The second protein has a MW of 190,000. Interestingly, this neuraminic acid binding protein
was not found in the SDS-PAGE after absorption of solubilized membrane proteins withl
guinea-pig erythrocytes, indicating that this protein is probably one possible receptor for
neuraminic acid residues in cell surface of erythrocytes and therefore involved in thle well-
known attachment phenomena. These findings correspond to the results of other researchl
groups which could identify by monoclonal antibodies an attachment-inhibiting protein with a
MW of
- 190,000.
In conclusion, these results verify glycoproteins and sugar-binding proteins as building
stones in membrane composition of mycoplasmas and show that mycoplasmas are provided
with their own binding mechanisms, several lectins, which could explain their adherenice to the
surface of eucaryote tissue.
oi
0
0Isolation of Plasmids in Ureaplasma urealyticum. H. Blenk. Ernst Rodenwaldt In-
stitute, Koblenz, West Germany; and G. Jahn. Institute for Clinical Virology, Uni-
versity Erlangen-Nurnberg, West Germany
Tetracycline resistance in ureaplasma has been described in the last years by several groups.
In our laboratory we observed in some of these strains the phenomenon that the resistance de-
creased after frequent passages; we therefore supposed the tetracycline resistance might be
codified by R plasmids.
From a patient with a penicillin- and tetracycline-resistant gonorrhea (pen MIC > 1,000
g/ml, tc MIC - 10 g/ml) we could isolate ureaplasmas, which were also resistant against tetra-
cyclines (MIC
- 10 g/ml).
In the gonorrhea strain we found two R plasmids, one typical PenR Plasmid (asiat. Typ 4.4
Mdalton) and one untypical TcR Plasmid (- 9.6 Mdalton) [Jahn et al., 1982].
In this cloned ureaplasma strain we could also isolate two plasmids, a small (4.9 Mdalton)
and a large one (- 8.1 Mdalton). Interestingly, the large plasmid has nearly the same size as
the TcR plasmid of the gonorrhea strain. This result leads to the supposition that ureaplasmas
possibly are provided with R plasmids which are similar in size to corresponding plasmids
found in bacteria. A plasmid transfer between gonococci and ureaplasmas might be possible.
Membrane Lipids of Mycoplasma orale. Y. Hirai, S. Kukida, K. Tomochika,
Y. Kanemasa. Okayama University Medical School, Okayama, Japan; and A.
Okabe, H. Hayashi. Kagawa Medical School, Kagawa, Japan
Mycoplasma requires cholesterol and long fatty acids for growth. Those components seem
to be essential for building up the plasma membrane. However, information on the compo-
sition and the metabolism of the membrane lipids of mycoplasma has been fragmented and
scattered [1]. Detailed studies on the membrane lipids of mycoplasma are the most important
task yet to be done in order to understand thegeneral mechanism ofmembrane biogenesis. We
studiedthecomposition andthemetabolismofmembranelipids ofMycoplasmaorale, attempt-
ing to elucidate the characteristics of the membrane lipids biogenesis.
Material andMethods: Mycoplasma orale CH 19299 was cultured in Hayflick's medium [2]
containing freshly prepared horse serum at a concentration of 15 percent for48 hours at 37°C.
Lipids were extracted by the method of Folch and isolation and identification was carried out
on silica gel G TLC. GC was used for analysis of fatty acids and H332P04, 14C-acetate,
'4C-arginine, and '4C-palmitic acid were used for the examinations of lipid synthesis.
Results andDiscussion: The membrane lipids consisted of neutral lipids (43.5 percent) and
phospholipids (56.5 percent). Among the neutral lipids, 64 percent was cholesterol, 9 percent
was cholesteryl ester, and the rest were mainly triglycerides. Phospholipids comprised 53 per-
cent of sphingomyelin, 32 percent of phosphatidylglycerol, and 15 percent of phosphatidyl-
choline (Table 1). There was no lysophosphatidic acid, cardiolipin, or glycosyldiglycerides.
The fatty acid components were restricted to palmitic acid and stearic acid regardless ofphos-
pholipid species (Table 2).
TABLE 1
Lipid Compositions of M. orale and Horse Serum
M. orale Horse serum
% in total (% in fraction) % in total (% in fraction)
Phospholipids 56.5 (100) 37.6 (100)
Phosphatidylglycerol 18.0 ( 32) 1.1 ( 3)
Phosphatidylcholine 8.5 ( 15) 26.5 ( 70)
Lysophosphatidylcholine - 6.1 (16)
Sphingomyelin 30.0 ( 53) 3.9 (10)
Neutral lipids 43.5 (100) 62.4 (100)
Cholesterol 28.0 ( 64) 6.6 (11)
Cholesterol ester 3.9 ( 9) 19.3 ( 31)
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TABLE 2
Fatty Acid Compositions of M. orale and Horse Serum
M. orale Horse serum
FA PC SPM PG Total PL Total PL Total L
C14:0 1.0 0.8 1.3 1.1 0 0
C16.0 64.8 80.4 69.7 71.3 24.4 25.1
C16:1 0.5 Trace 0.7 0.4 0 0
C18,0 25.3 15.8 27.5 23.6 29.5 20.2
C18,1 2.5 3.0 0.8 1.9 6.6 9.4
C18,2 5.9 Trace 0 1.7 39.4 45.3
Values are expressed as %
FA: Fatty acid, PC: Phosphatidylcholine, SPM: Sphingomyelin,
PG: Phosphatidylglycerol, PL: Phospholipid, L: Lipid
Lipid compositions of horse serum, which was the major lipid source in the culture medium,
were also shown in Table 1. This seems to indicate thatM. oraletakes up phosphatidylcholine,
sphingomyelin, and cholesterol selectively from the medium, with preference for palmitic acid
and stearic acid as the fatty acids components (Table 2).
Incorporation experiments of orthophosphate (32P) into phospholipids showed that
phosphatidylglycerol was the only phospholipid synthesized by M. orale. Fatty acids were not
synthesized by the cell with '4C-acetate or 14C-arginine as the substrates. '4C-palmitic acid was
exclusively incorporated into phosphatidylglycerol (Table 3).
TABLE 3
Incorporation of 14C-palmitate into the Lipids of Mycoplasma Membrane
Lipids dpm Lipid phosphorus (ug) dpm/Lipid phosphorus (ug)
Phosphatidylglycerol 1605291 4.9 327610
Phosphatidylcholine 3573 2.5 1429
Sphingomyelin 781 5.6 139
Neutral lipids 3678 0
The results made clear the following points: M. orale was able to synthesize glycerophos-
phate in the cell and conjugate it with exogenous fatty acids which were taken up by means of
a specific carrier system in the membrane. Sphigomyelin and phosphatidylcholine seemed to be
incorporated into the membrane without any modification but through a selective carrier sys-
tem for C16:0 and C,8:0 fatty acids. Cholesterol was taken up directly from the medium, possibly
by a specific binding protein in the membrane [3,4].
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In Vitro and in Vivo Activities of Miocamycin (Midecamycin Acetate) and a I
tabolite, Mb-12, on Mycoplasmapneumoniae. T. Watanabe, K. Miyauchi, Y. I
zuno, T. Kojima, S. Inouye. Central Research Laboratories, Meiji Seika Kais
Ltd., Japan; E. Hayatsu, Y. Kawakubo. The Kitasato Institute, Japan; and
Yoshioka. Tokyo Women's Medical University, Tokyo, Japan
Miocamycin (MOM) is a semisynthetic 16-membered macrolide derived from midecamycin
(MDM) by introducing two acetyl groups at C-3" and C-9 positions. MOM exhibits potent an-
tibacterial activity against gram-positive bacteria and gram-negative cocci. One of the mainPOSTER SESSIONS 895
metabolites in human beings is 4"-acetyl-4'-depropionyl-midecamycin (Mb-12), which is also
bioactive.
Macrolide antibiotics have been used as the drug of first choice in the treatment of Myco-
plasmapneumoniae pneumonia. However, there has been little report on experimental chemo-
therapy on mycoplasmal pneumonia. We studied in vitro and in vivo activities of MOM and
Mb-12 on M. pneumoniae. MDM, erythromycin (EM), josamycin (JM), and other macrolides
were used as references. Sensitivity distribution of 100 clinical isolates of M. pneumoniae ob-
tained from hospitals in Japan indicated that mean MIC value of MOM required to inhibit 50
percent strains (MIC50) was 0.0078,g/ml, which was higher than MIC50 ofEM (0.0039Ag/ml),
but lower than those of MDM (0.0313 ,g/ml) and JM (0.0156 ug/ml). We found a strain that
was resistant to EM but susceptible to MOM. In vitro study of Ureaplasma urealyticum, which
is close to Mycoplasma species, showed that MOM was the most active among the macrolides
used in clinic. MICso values against four strains of U. urealyticum were 0.05 /g/ml for MOM,
0.20 ug/ml for JM, 0.39 ug/ml for MDM, 0.78 ug/ml for EM, 6.25 Ag/ml for triacetylolean-
domycin, and 6.25-12.5 gg/ml for spiramycin.
The in vivo effect of MOM was examined using an experimental pneumonia in golden
hamsters challenged with M. pneumoniae FH-P24 by the aerosol inhalation method. The
MICs against this strain were 0.0156 tg/ml for MOM, 0.125 'gg/ml for Mb-12, 0.0313 Ag/ml
for MDM, 0.0078 Ag/ml for EM, and 0.0313 ,g/ml for JM. The hamsters were orally treated
with an aqueous suspension of MOM a week after infection, and treatment was continued for
seven days. When it is judged from the number of viable cells that remained in the lunigs (Fig. 1),
the therapeutic efficacy of MOM was comparable to that ofEM at doses of 1,000 mg and 500
mg/kg, but slightly inferior to EM when treated with 100 mg/kg. On the other hand, MOM
was superior to MDM in efficacy at all dosages tested. When compared with Mb-12, MDM,
and JM at a dose of 300 mg/kg, MOM was most active, followed by MDM, JM, and Mb-12.
Histopathological examination on the lung specimens revealed that mononuclear cells in-
filtrated markedly in the bronchial cavity and around the bronchi in the untreated controls,
whereas slight and local infiltration of mononuclear cells and no bronchitis were observed in
the animals given 500 mg and 100 mg/kg of MOM. In contrast, bronchitis and peribronchial
inflammatory change were observed in the animals given 500 mg/kg of EM. At a dose of 300
mg/kg, MDM caused a little less severe lesion than JM, though notable infiltration of mono-
nuclear cells was observed in both cases. Scanning electron microscopy of the peribronchial
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reduced by treating with 500 mg/kg of MOM. The surface of the microvilli treated with MOM
was relatively smooth, but that treated with EM was rough, consistent with the histopathologi-
cal findings.
These results were suggestive of potential use of MOM in the chemotherapy of M. pneu-
moniae pneumonia in clinic.
Heat Inactivation and Preincubation-Induced Activation of Arginine Deiminase of
Mycoplasma. Hideo Nagayama. The Research Institute for Tuberculosis and Can-
cer, Tohoku University, Sendai, Japan; Koko Ueda. Sendai Kosei Hospital, Sendai,
Japan; and Yasutaka Niitu. The Research Institute for Tuberculosis and Cancer,
Tohoku University, Sendai, Japan
We have studied arginine deiminase activity ofmycoplasma. The heat inactivationi curve in-
dicated that the enzyme activity was increased-activated-by the preincubationi ofthe enzyme
at 37°C and neutral pH. The characteristics ofthe activation process ofthis enzyme were studied.
Cell-free enzyme solution was prepared by sonication in PBS from the four species ofmyco-
plasma, M. hominis, M. orale, M. salivarium, and M. fermentans, grown in PPLO broth.
Arginine deiminase activity was measured by the determination of the NH3 formed by the in-
dophenol method after incubation for 15 minutes at 37°C. The heat inactivation curve of the
enzyme was made at 37°C, 50°C, 55°C, 60°C, 65°C, and 70°C. The results and analysis ofthe
time course ofthe heat inactivation theoretically showed that the enzyme from the four species
should increase in activity after being kept at 37°C and that activation must be most prominent
in M. hominis. The following experiments were made with the enzyme solution from M. homi-
nis to elucidate the activation mechanism.
Arginine deiminase activity was increased by the preincubation of the enzyme solution at
37°C. The activation reached a plateau after 15 minutes. ATP and cAMP were ineffective on
the activation. Dialysis of the enzyme solution abolished the activation. EDTA, which did not
affect the enzyme activity itself, exhibited a marked inhibition of the activation. Of the in-
hibitors tested, only PCMB (p-chloromercuribenzoate) showed a complete inhibition ofthe ac-
tivation, while iodoacetate and N-ethylmaleimide did not. PCMB also slightly inhibited en-
zyme activity itself. As to SH reagents, dithiothreitol (DTT) inhibited at 5 x 10-6 - 5 x 10-4
M but stimulated at higher concentrations, showing a diphasic effect, which proved due to its
chelating action, while f.-mercaptoethanol was ineffective. The enzyme which had once been
made inactive by dialysis again became susceptible to activation after it had been freeze-
thawed in the presence of PBS.
In summary, arginine deiminase from the four species of mycoplasma was shown
theoretically to increase in activity after preincubation at 37°C from the heat inactivation
curve. Ions and conformational changes of the enzyme protein are possibly involved in the ac-
tivation process.
Isolation of Mycoplasma pneumoniae Microfilaments. Ulf Gobel. Institute for
General Hygiene and Bacteriology, University ofFreiburg, Federal Republic ofGer-
many
Despite the lack of a rigid cell wall, all motile Mycoplasma species show aconstalnt cell sliape
characterized by polar structures at the leading edge of the gliding cells. The reason for this is
still unknown. Reports of the isolation of an actin-like protein from cell extracts of M. pneu-
moniae and the observation of a cytoskeleton in the same organisms suggested a possible rela-
tionship between these structures and the mainteniance of cell shape and glidinig motility [1,3].
In this study we attempted to isolate the actin-like protein as well as the intact microfilaments
for future studies on the chemical nature and functionial properties of this organelle. In addi-
tion we wish to further characterize the nature of the microfilainent-membranie interactionl.
Affinity chromatography on DNase-Sepliarose has been used to purify theactin-like protein
as described by Lazarides and Lindberg [2]. 35S-methioniine labeled organiisms were harvested,
washed, and ultrasonicated after lysis in 10 mM Tris buffer, pH 8.0 containlilng 10 percent
glycerol, 1 mM CaCl2, 0.1 mM PMSF, and 0.1 mM dithioerytlhritol (probe buffer). The lysate
then was applied to the affinity chromatograplhy column. Unbounid material was washed outPOSTER SESSIONS 897
with probe buffer, followed by subsequent elution with 0.3 M and 3.0 M guanidinium-HCl.
Aliquots of the different fractions containing equal counts were analyzed by SDS-PAGE and
autoradiography. In the 3.0 M guanidinium eluate we found a polypeptide co-migrating with
rabbit muscle actin.
The intact microfilaments were isolated by a modified differential centrifugation procedure
described for the isolation of membrane-associated microfilaments from eukaryotic cells [4].
The mycoplasma cells were lysed with 1 percent Triton, containing 5 mM MgCl2, 0.1 M KCI,
50 ug/ml phalloidin, and 0.1 mM PMSF. After ultrasonication the lysate was centrifuged at
low speed in order to eliminate larger aggregates. The supernatant was then centrifuged at
40,000 g for 30 minutes (Airfuge, Beckman). The pellet was resuspended in a buffer containing
5 mM ATP, mixed vigorously, and allowed to stand on ice for one hour. The suspension was
subsequently centrifuged at 80,000 g for 20 minutes.
All fractions were examined for the presence of microfilaments by electron microscopy.
Only the 80,000 g supernatant contained considerable amounts of microfilaments and was
called "microfilament-rich fraction." Parts of this fraction were dialyzed against a buffer con-
taining 15 mM MgCl2 in order to induce bundle or paracrystal formation. After dialysis the
filaments were directly pelletted on parlodion-carbon coated copper grids. The isolated fila-
ments were morphologically identical with those found after in situ lysis. Even after prolonged
dialysis, no paracrystal formation occurred. Analysis of the microfilament-rich fraction by
SDS-PAGE and autoradiography revealed a complex protein pattern with five major poly-
peptide bands with molecular weights of 61, 50, 42.5, 39, and 33 kilodalton, respectively. The
42.5 kd protein co-migrated with rabbit muscle actin.
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Growth Inhibition of Cell Cultures by Extracts of Arginine-Utilizing Mycoplasma
Species. M. Shintani, T. Sasaki, K. Kihara. National Institute of Health, Tokyo,
Japan
Mechanism of the growth inhibition of mammalian cell cultures due to mycoplasma con-
tamination was investigated by using extracts of fourteen species ofmycoplasmas and four cell
lines.
Mycoplasmas grown in the stationary phase were harvested by centrifugation at 15,000g for
40 minutes, washed, and sonicated for 10 minutes. The sonic extract was centrifuged at
40,000 g for 60 minutes and filtered through a 0.22Am Millipore filter. The filtrate was stored
at -20°C and used as "mycoplasmal extract." The mycoplasmal extracts were diluted with
fresh cell culture medium containing 5 x 104 cells per ml. After incubation in a 5 percent
CO2-95 percent air incubator, the number of the cells and the amount of arginine in the
medium were determined.
5xl O 7 .5
4 E .0
K. 05 E FIG. 1. Relationship between the
growth inhibition of FM3A cells and the
depletion of arginine from MEM by M.
c hominis extract. aDetectable limit of
, lx10 < _ {10 arginine. The concentrations of M. 40 to~~~~~~~~~~~0 E5x104, .Go05.c hominis extract added to the medium
E O i 4 were as follows: 0, 0; 0, 1:5,000; A,
z Days in culture < 1:3,000; A, 1:1,000.POSTER SESSIONS





V + - x + + + + + +
x
0 ~ ~ ~ ~ ~ ~ ~ ~ ~
X ++
u~~~~~~~~~~~~~~~~~~~~~~~~C








o : e o _n oo ON o n _ _ 1N oo 0 <> "] IC tn ^o W °s in -. 0 :Ne
0 d C; C; C5 ( <>
O<6 O;<6 6 C; t6t
LI0 E E- E







0 ' *M.gallinarum c' 2 M.orale
*M.arthntidis
fo .c 1 M.iners
Et *Mprimatum FIG. 2. Relationship between the ac-
' r=O.960 tivity of arginine deiminase and the cell
Q2 (p<oo1) growth-inhibiting activity ofmycoplasmal
8 ek *M.fermentans extracts. 'Reciprocal of the highest
Qi 50 200 800 3200 dilution of mycoplasmal extract which
o, Cell growth-inhibiting activitya) reduced the cell growth to less than 50
v) percent of that of control.
The extracts of arginine-utilizing mycoplasmas, including M. hominis, inhibited the growth
of FM3A and MDCK cells, while those of glucose-utilizing mycoplasmas did not. Growth of
Vero and LLC-MK2 cells was not inhibited by either arginine- or glucose-utilizing mycoplas-
mal extracts (Table 1).
Addition ofM. hominis extract to FM3A cellculture resulted in rapid decrease ofarginine in
the culture medium. When arginine was not detected in the medium, thegrowth ofFM3A cells
was inhibited (Fig. 1). The inhibition by the extract was prevented by adding excess amounts of
arginine. Vero and LLC-MK2 cells, however, grew well in the arginine-depleted medium. A
high positive correlation (r = 0.96, p = 0.01) was found between the specific activities of
arginine deiminase and the growth-inhibiting activities on FM3A cells of the extracts of
arginine-utilizing mycoplasmas (Fig. 2). The inhibiting activity of M. hominis extract was
preserved after dialysis but was lost after heating at 70°C or treatment with 10-4M p-chloro-
mercuribenzoate.
These results suggest that growth inhibition ofthe cells by arginine-utilizing mycoplasmal ex-
tracts is due to arginine depletion from the medium by arginine deiminase, and that this en-
zyme participates in the growth inhibition of cell cultures contaminated with arginine-utilizing
mycoplasmas. Different growth inhibition according to different cell lines by each ofarginine-
utilizing mycoplasmas and of their extracts is partly explained by differences in arginine re-
quirement among the cell lines.
Mycoplasmal Mediated Cytotoxicity: Its Use in Indirect Detection of Cell Culture
Infection. G.J. McGarrity. Institute for Medical Research, Camden, NJ; and D.A.
Carson. Scripps Clinic and Research Foundation, La Jolla, CA
A variety of procedures have been developed to detect mycoplasmal infection (MI) in cell
cultures. Beside microbiological assay, indirect detection methods have assayed for gene prod-
ucts specific to mycoplasmal infected cultures and not found in mycoplasmal-free cultures [1].
In several systems, the assay is for uptake or conversion of a radioactive isotope. The pres-
ent system assays for mycoplasmal mediated cytotoxicity, requiring only a light microscope.
Mycoplasmas and other prokaryotes contain significant levels of adenosine phosphorylase
(AP) activity, which converts adenosine to adenine; AP can also produce adenosine from
adenine and ribose-l-phosphate. Mammalian cells have little if any adenosine phosphorylase
activity. We have developed an indirect detection system based on the presence of AP in my-
coplasmas, but not in mammalian cell cultures. Addition of 10 4M of a purine analogue,
6-methylpurine deoxyriboside (6MPDR), has no effect on mycoplasma-free cell cultures. In
the presence of mycoplasmal AP, 6MPDR is converted to two potent anti-metabolites, 6
methylpurine and, if ribose-l-phosphate is available, to 6 methylpurine riboside as well. These
anti-metabolites kill mammalian fibroblast cell cultures in concentrations as low as 2 sM. A
standardized 6MPDR assay procedure has been developed using 3T6 indicator cell cultures.
This procedure will assay for both supernatant and cytadsorbed mycoplasmas. This has
detected infections with mycoplasma, acholeplasma, and spiroplasma species. 6MPDR
mediated cytotoxicity was produced in cultures infected with M. hyorhinis, M. orale, M.
arginini, M. salivarium, M. hominis, M. fermentans, M. buccale, M. sp 70-159, A. laidlawii,
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and S. citri. No cytotoxicity has been observed in 12 different mycoplasma-free cell culture
types after addition of 10 zM 6MPDR. These cell culture types included fibroblast, lympho-
blastoid, hybridoma, endothelial, smooth muscle, kidney epithelial, eye lens, and insect cell
cultures. No false positives or negatives have been detected in assay of more than 120 cell
culture specimens in the 3T6 indicator system. This survey is continuing. The analogue is non-
toxic to mycoplasmas.
The 6MPDR assay is easy to perform, requiring only the cell culture to be assayed, the 3T6
or other appropriate indicator cell culture known to be free ofAP, a supply of6MPDR, and a
light microscope. The cytotoxicity seen in infected cultures is easily recognized; the degree of
cytotoxicity infected is at least 50 percent; frequently all the cells are killed.
Our present assay involves the inoculation of 1.5 x 103 3T6 onto 22 x 30 mm No. 1
coverslips and grown in MEM + 10 percent fetal bovine serum; equivalent cell culture media
that promotes 3T6 growth can be substituted. Twenty-four hours later, 0.1 ml ofthe specimen
cell culture is inoculated; two to three days later, 10 MM 6MPDR is added. Cytotoxicity be-
comes apparent in infected cultures three to four days later. A report on this system has been
published [2]; studies are continuing.
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Characterization of Spiroplasma mirum in Cell Cultures. Francis Megraud, L. Ga-
mon, J. Sarama, V. Vanaman, G. McGarrity. Institute for Medical Research, Cam-
den, NJ
Spiroplasma mirum is pathogenic when injected intracerebrally into suckling rodents. The
objective ofthe present studies was to determine ifa cell culture system could be developed that
was appropriate for the study of S. mirum. AG-4676, a line developed by Reddan et al. [1]
from rabbit eye lens, was investigated. Rabbit eye lens cells constitute an appropriate in vitro
model since (1) rabbit lens is a target tissue for S. mirum, and (2) lens cells in vivoare devoid of
innervation, avascular, derived solely from ectoderm, and encapsulated.
10' CCU of S. mirum were inoculated into AG-4676. Infected cultures became granular and
vacuolated six to seven days after infection when S. mirum reached peak titers, 108 CCU/ml.
Infected AG-4676 cell counts decreased 0.5-1.0 logs in seven to nine days, compared to con-
trols. At seven days, fluorescent DNA staining revealed clusters of non-helical, filamentous S.
mirum absorbed onto AG-4676 cells and the coverslip. S. mirum did not grow in MEM + 10
percent fetal bovine serum, the medium for AG-4676. Conditioned medium from five-day
cultures of AG-4676 supported growth of S. mirum to approximately the same titers (108
CCU/ml) as SP-4 medium (109 CCU/ml), but with a much shorter lag period. Preliminary
studies indicate this growth is due to a physiologic conditioning of the medium, rather than
specific growth factors.
S. mirum also grew in cell lines Rab-9, a rabbit fibroblast, MRC-5, a human diploid fibro-
blast, and 3T6, a mouse embryo fibroblast, but with little cytopathology. After ten passages in
AG-4676, S. mirum produced deaths or cataracts in sucking rats (55/60), significantly higher
than spiroplasma-free AG-4676 (4/37), and similar to S. mirum propagated in SP-4 medium
(53/65).
Appropriate cell and organ cultures may serve as model systems for S. mirum and other
spiroplasmas. S. mirum has been studied in rabbit eye lens organ culture [2] and drosophila cell
cultures [3]. Related organisms have been isolated in tick cell cultures [4]. These and other in
vitro systems may facilitate studies in the characterization, natural history, and pathogenicity
of the spiroplasmas.
REFERENCES
1. Reddan J, et al: Vision Res 21:1-23, 1981
2. Fabiyi A, Elizan TS, Pounds JE: Proc Soc Exp Biol Med 136:88-91, 1971POSTER SESSIONS 901
3. Steiner T, McGarrity GJ, Phillips DM: Infect Imm 35:296-304, 1982
4. Tully JG, et al: Science 212:1043-1045, 1981
Morphological Studies on Spiroplasma mirum Strain SMCA Grown in Modified
Hayflick Medium. R. Rosengarten, H. Kirchhoff. Institut fur Mikrobiologie und
Tierseuchen, Tierarztliche Hochschule, Hannover, Federal Republic of Germany
Spiroplasma sp. strain SMCA (suckling mouse cataract agent) originally isolated from rab-
bit ticks, and recently designated as Spiroplasma mirum [Tully et al., 1982], has been cultivated
by Tully et al. [1977] in artificial medium containing the rich CMRL-1066 tissue culture supple-
ment and fetal calf serum. As Liao and Chen 11979] did, we were able to adapt strain SMCA to
a more simple medium ofthe following composition: Difco PPLO broth, 70 percent; unheated
horse serum, 20 percent; fresh yeast extract, 10 percent; glucose, 0.1 percent; phenol red, 0.002
percent; penicillin, 2000 IU/ml. The pH was adjusted to 7.6. Strain SMCA was cultivated in
this medium at 37°C in an atmosphere of 5 percent CO2.
In fluid medium, strain SMCA showed a flocky growth, resulting from the formation of
colony-like cell aggregations. In addition, bottom colonies of round and irregular shape
developed in fluid medium, showing the ability of strain SMCA to attach to surfaces.
On solid medium colonies developed after 24-96 hours. Different types of colonies were
observed depending on the agar concentration used. Typical fried-egg colonies developed on 3
percent agar medium. Colonies with the formation of satellite colonies were observed growing
mostly in the depth of the agar medium on 2 percent agar medium; the satellite colonies
developed from migrating SMCA cells. Using single SMCA cells, produced by filtration of a
fluid SMCA culture (450 nm filter) for inoculation, on 1 percent agar medium colonies con-
sisting of irregular accumulations of SMCA cells and asteroid colonies developed in the depth
of the agar medium. After inoculation with an unfiltered fluid SMCA culture, fried-egg-like
colonies appeared on 1 percent agar medium. These colonies developed from microcolonies
(flocks) of the fluid medium. In general, the fried-egg-like colonies were surrounded by single
spiroplasma cells migrating from the parent colony. In addition, in 1 percent agar medium col-
onies of round or irregular shape developed at the bottom of the petri dishes, indicating the
ability of SMCA to migrate through the agar medium. The diameter of the colonies varied be-
tween 0.05 and 0.1 mm on 3 percent agar medium, between 0.4 and 0.45 mm on 2 percent agar
medium, and between 5 and 7 mm on 1 percent agar medium. Production of a conspicuous
film and spots was observed on 1 percent agar and on the surface of the fluid culture and to a
lesser degree on 2 percent agar. Results are summarized in Table 1.
The shape of the single SMCA cell varied with the time of cultivation. After incubation of
one to two days, short SMCA cells with two to five turns predominated. During incubation
SMCA cells became longer. After two to three days most of the SMCA cells had 10 to 20 turns,
and after three days asteroid cell aggregations appeared. Degenerated spiroplasma cells were
observed from the fifth day of incubation.
TABLE 1
Growth Characteristics of Spiroplasma mirum Strain SMCA
1I% agar 2%7o agar 3%70 agar
Surface growth + (+) +
Irregular accumulations of cells
below the agar surface + (+)
Satellite colonies at the bottom
of the agar plate +
Film and spots reaction + (+)
Appearance of colonies
(days after inoculation) 1-2 2-3 3-4
aDevelopment of surface colonies after inoculation with unfiltered
fluid culture onlyLack ofSerological Relationship Between the Aster Yellows Agent and Spiroplasma
citri Determined by ELISA Assay. R.E. McCoy, H.G. Basham. Agricultural Re-
search and Education Center, Fort Lauderdale, FL
Madagascar periwinkle plants were graft-inoculated with scions from periwinkle vector-
inoculated with Spiroplasma citri or with the aster yellows organism (AYO). Plants were incu-
bated for about six weeks. Symptoms associated with the two organisms were stunting of
leaves and flowers for S. citri and stunting, proliferation, and virescence for the AYO. Symp-
toms were easily differentiated on visual inspection. Isolations made from symptomatic plants
in LD-8 broth yielded cultures of S. citri from the S. citri inoculated plants as determined by
growth inhibition assay. Similar isolations from AYO-infected plants or healthy plants failed
to yield any growth. Transmission electron micrographs of semi-thick sections of phloem tis-
sues revealed helical filaments in the S. citri infected plants, whereas polymorphic bodies only
were visible in AYO-infected plants. Young plant tops(0.5 g) were ground in phosphate buffer
(0.2 M), made to 0.33 M inNaCl,1 percent PVP, and 0.2 percent BSA. Standard ELISA assays
with S. citri antibody were run in four replicate assay plates using eight replicate plants from
each of the two treatment groups. Controls, consisting of five healthy plants and healthy plant
material with added S. citriantigen(1:1 plant extract + logphase S. citriculture) were included
on each assay plate. Results wereexpressed as a percentage of the ELISA reactivity of the con-
trols spiked with S. citri culture. The entire experiment was repeated with the same results. S.
citri inoculated plants were 20percent as reactive in ELISA assay for S. citri as the culture con-
trols. AYO-infected and healthy plants showed no S. citri reactivity. A young culture of the S.
citri isolate from which the ELISA antibody was prepared gave an absorbance of 0.4 in the
ELISA assay system. Cultures of the "lettuce-AY spiroplasma" at the same dilution gave an ab-
sorbance of0.3 in the sameplates. These datasupport the hypothesis that the organism causing
aster yellows is not related to S. citri.
Electron Microscopy of Spiroplasma (SMCA). Z. Yoshii, H. Konishi. Yamaguchi
University School ofMedicine, Ube, Yamaguchi-ken, Japan; and Y. Yoshitake, M.
Nakamura. Kurume University School of Medicine, Kurume, Fukuoka-ken, Japan
Purpose: Scanning electron microscopic (SEM) and transmission electron microscopic
(TEM) observations of SMCAgrown in liquid culture medium were carried out fromthe view-
points of three-dimensional status of cell body and pleomorphism.
Materials andMethods: (1) Sample: SMCA was cultured in SP-4 broth at37°C for six days.
(2) Specimens: For SEM, the SMCA was fixed with1 percent glutaraldehyde and 2 percent
osmic acid, then was dried in a critical point drying (CPD) instrument, and coated with Au-Pd.
For TEM, the SMCA was fixed in 2percent glutaraldehyde and washed three times with PBS.
After mounting on the supporting membrane, the specimens were shadowed with chromium,
or negatively stained with 1 percent uranyl acetate.
Results and Discussion: Some examples of SEM and TEM images are illustrated in Figs.
1-5. The results obtained are summarized as follows:
Helical status and spiral direction of the spiral cell body appears in SEM images (Figs. 1,2).
The cell body usually showed acomplete turn and regular spirals of about 660 nm length each.
The number ofspirals are variable, between three and ten turns. The spiral direction was defi-
nitely left-handed.
Morphological classification of SMCA in EM images: Pleomorphic features could be seen
± FIG. 1.
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FIG. 2.
FIG. 3.
among them; however, the following arrangement may be made: (1) monotonous shape group:
straight or winding form (Figs. 1,2,4); (2) branching shape group: Y, V, or other complicated
letters, or cactus-like (Figs. 2-4); (3) Spherical shape group: spherical or granular form (Figs.
2,4); (4) miscellaneous group: complicated form (Fig. 3); (5) combined or intermediated shape
group.
The findings mentioned above and the significance ofthe pleomorphism are very difficult to





0*1The Occurrence of Fibril Protein in Spiroplasma and Spiroplasma-Infected Hosts.
R. Townsend, D.B. Archer. John Innes Institute, Norwich, England
Fibrils were purified from the BC3 strain ofSpiroplasma citriand electrophoresed in sodium
dodecyl sulphate (SDS) polyacrylamide gels (PAG's). An antiserum was raised in rabbits using
fibril protein monomer (MW 55,000), excised from PAG's which had precipitating activity
against SDS denatured but not native fibril protein. This antiserum was used in combination
with protein (Western) blotting ofpurified protein and whole-cell preparations electrophoresed
in SDS-PAG's. Less than 0.5 ng of fibril protein could be detected, and 55,000 MW antigen
was shown to be present in each of thirteen different spiroplasmas, including nonhelical strains
of S. citri, representing five different serogroups. The antiserum did not react with proteins in
any of the Mycoplasma or Acholeplasma species tested, which included those known to con-
tain fibrilar structures. Two-dimensional immuno-electrophoresis confirmed the presence of
fibril protein in all spiroplasmas but revealed variations in the amount of the antigen in dif-
ferent isolates even among the same serogroup. Peptide mapping by limited proteolysis in SDS
showed that fibril protein was highly conserved within a serogroup but that there was some
heterogeneity between serogroups. However, all fibril proteins yielded at least one peptide
recognized by the antiserum. Spiroplasma fibril protein could also be detected in Triton X-100
insoluble extracts from Catharanthus roseus plants infected with S. citri or corn stunt at a level
of detection equivalent to 104spiroplasmas per mg ofwhole tissue. The same antigen could not
be detected in C. roseus infected with seven different "yellows" diseases in which mycoplasma-
like organisms (MLO's) were present at high concentrations or in Opuntia tuna monstrosa cac-
tus. These findings indicate that the non-cultivable MLO's associated with the majority of
yellows diseases are not spiroplasmas.
Isolation and Preliminary Characterization of Mycoplasma Virus 20-P. E. Jansson,
A. Backman, K. Hakkarainen. Institute of Biomedical Sciences, University of
Tampere, Finland; C.-H. von Bonsdorff. Institute of Virology, University of Hel-
sinki, Finland; and B. Seniusova, A. Miettinen. Institute of Biomedical Sciences,
University of Tampere, Finland
A mycoplasma virus, MV 20-P, was isolated from the fastidious, slow-growing human
mycoplasma 20-P, previously identified by the growth inhibition test as Mycoplasma hominis
type 2 [Ann NY Acad Sci 143:535-543, 1967]. Its broth culture was ultracentrifuged into 35
percent saccharose, the pellet was resuspended in buffer, and the suspension was dropped onto
lawns of the virus indicator Acholeplasma laidlawii BCL-13. The virus was washed off the
plaque areas by buffer. MV 20-P appeared in electron microscopy as spherical, enveloped par-
ticles about 80 nm in diameter. It was sensitive to lipid solvents. These preliminary results in-
dicate that MV 20-P is a MVL2 type mycoplasma virus and possibly the first of human origin.
Spiroplasma Viruses in Plants. A.S. Alivizatos, P.G. Markham, K. Plaskitt. John
Innes Institute, Norwich, England
It has been reported that a spiroplasma virus type-C3 (SVC3) was observed in Catharanthus
roseus plants infected with a strain of Spiroplasma citri (SPC3) which produces only mild
symptoms [Alivizatos AS, et al: Ann Appl Biol: 101, 1982]. Spiroplasma virus type-CI (SVCI)
and C2 (SVC2) are also produced by this strain within plants. C. roseus plants grafted first
with a lethal strain of S. citri (SPA) and subsequently with the strain SPV3 develop compara-
tively mild symptoms and do not die, whereas plants infected with only SPA show severe symp-
toms and die within a few weeks, depending on conditions. Plants also infected with SPV3
strain of S. citri have survived for several years, with symptoms which fluctuate between very
slight and localized to mild. The expression of symptoms depends to a certain extent on the
nutritional status of the plant. However, some plants have shown total recovery, as measured
by the normal growth of leaves and flowers, and the inability to re-isolate spiroplasmas or to
see spiroplasmas by electron microscopy.
Multiple challenge experiments in which corn stunt spiroplasmas (CSS), S. citri (SPA), and
S. citri (SPV3) have been tried in various combinations have shown that plants infected with
CSS and SPV3 will survive.
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The evidence so far strongly suggests that the spiroplasma viruses play a role in preventing
the usually lethal effect of S. citri (SPA).
Sex Ratio Organism (SRO) Can Affect Male Drosophila Cells in Vitro. T. Koana.
International Christian University, Mitaka, Tokyo, Japan; and R. Ueda, T.
Miyake. Mitsubishi-Kasei Institute of Life Sciences, Machida, Tokyo, Japan
Sex ratio organism (SRO), a spiroplasma-like parasitic microorganism, is known to cause
the sex ratio phenomena in several species of fruit fly Drosophila [1]. SROs are maternally
transmitted and kill the male zygotes during embryogenesis while the daughters are not af-
fected. Genetical analyses in D. melanogaster revealed that flies with two or more X chromo-
somes are resistant to SRO, while those with a single X are sensitive regardless of their pheno-
typic sex [2,3]. Gynandromorphs with both male and female body parts could survive under
SR condition when the ventral region on the blastoderm fate map was occupied by female cells
[4]. This suggests that the primary target site ofSRO is in the ventral area ofthe fate map, most
likely in the primordial nervous system.
We examined the effects ofSRO on differentiation and growth in vitro ofembryonic cells of
Drosophila melanogaster. The single embryo culture technique and a histochemical staining
method for glucose-6-phosphate dehydrogenase (G6PD) activity were employed to distinguish
male embryo cultures from female ones. The G6PD deficient Zw" females were infected with
SRO from D. nebulosa, and crossed to wild-type Canton-S males. Early gastrulae were col-
lected, and the whole content of each single embryo was taken out and cultured in M3(BF)
medium by means of the column drop culture method (one embryo = one culture).
By phase contrast microscopy, degradation ofcells was observed in halfofthe single embryo
cultures, which indicated that SRO could affect Drosophila cells in vitro. The abnormality was
male-specific; that is, the morphological aberration was observed specifically in male (Zw'VY,
G6PD-) embryo cultures. The feature in female (Zwn/ +, G6PD') cultures was similar to that
in the uninfected embryo cultures. The symptom was also cell-type specific. Neurons, ima-
ginal disc cells, and plasmatocytes failed to differentiate in male cultures, while syncytial
macrophages, muscle, and fatbody cells were not so severely affected. The results are con-
sistent with the hypothesis which came from the gynandromorph analysis. Furthermore, we
can point out that these sensitive cell types are all XY diploid while the resistant types are not.
Muscle cells are syncytial and fatbody cells had polytene chromosomes. This suggests a pos-
sible correlation between SRO sensitivity ofthe cell and the number of X chromosomes similar
to the correlation at the individual level.
To test this hypothesis, established Drosophila cell lines were examined for SRO sensitivity.
Among the twelve cell lines examined, three were sensitive to SRO. Cells did not seem to pro-
liferate, and, within two days of the culture, they were destroyed to debris. The other nille cell
lines were resistant. Cells proliferated normally until they became over-confluenit. It has been
so far observed that the majority of cells in the two resistant lines had more thani two X
chromosomes. The karyotype of the other lines is now being analyzed.
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A Comparison of Routes of Inoculation on the Growth of Avian Mycoplasmas in
Chicken and Coturnix Quail Embryos. F.T.W. Jordan, S.M.M. El-Amin. Uni-
versity of Liverpool, Veterinary Field Station, Neston, Wirral, England
Although chicken embryos have been advocated for the isolation and propagation of myco-
plasmas, little attention seems to have been paid to determining the most satisfactory routes of
infection for this purpose. Thus an investigation was made with seven species of avian myco-
plasmas to determine the influence of six different routes of infection of chicken embryos on
the recovery of the organisms. Since unpigmented quail (Coturnix coturnix japonica) eggs
were also available, a similar study was made using them. It was hoped that the results mightindicate which route would be most helpful in recovery of mycoplasma from field material.
Embryonated eggs of both species from mycoplasma-free flocks were used and the routes of
inoculation were: onto the shell membrane, and dropped chorioallantoic membrane (CAM)
and into the albumen, allantoic cavity, amniotic cavity, and yolk sac. The organisms were M.
gallisepticum, M. synoviae, M. meleagridis, M. iowae, M. anatis, A. Iaidlawii, and the T916
isolate ofavian ureaplasma. Cultures of these organisms were grown in mycoplasma broth and
a high dose(10' CFU per egg) and low dose (102 CFU per egg) used. Ten eggs ofeach avian spe-
cies were inoculated by each route of inoculation for each ofthe organisms at the low and high
dose. After incubation for five days at 37'C, the site of inoculation and the oropharynx of
each embryo were separately swabbed with a standard loop and the swabs sowIn olnto
mycoplasma or ureaplasma media. The mycoplasma agar plates were incubated at 37'C
aerobically while the ureaplasma agar plates were incubated anaerobically at 37'C. If no
growth appeared by seven days the plates were discarded as negative.
Despite the large number of variables involved in this study (two species of host, six routes
of infection, and at different ages, seven species of organism each at two doses, and two sites
of harvesting) and the small number of embryos used, certain observations oni the recovery of
mycoplasma seem to be significant.
Route ofInfection Infection via the yolk sac gave the largest number of recoveries for all
seven species of organism irrespective of other factors while infection via the shell membranie
or onto the dropped CAM gave the least.
Infecting Dose ofOrganisms For almost all routes of inoculation and species of organlism
the larger dose gave greater numbers of recoveries.
SiteofHarvest Overall there were slightly more recoveries from the oropharynlx thanl from
the site of inoculation.
The Host The pattern of recoveries was similar for both chickeni and quail embryos.
Mycoplasmas With few exceptions M. anatis was recovered from more embryosthanl other
mycoplasmas, irrespective of almost all other factors, while A. laidlawii was recovered from
relatively few embryos except following yolk sac infection.
Live and Dead Embryos A relatively small number of embryos died following infectioni
and no definite conclusion can be drawn as to the influenice of embryo death on recovery of
organisms.
Growth of Mycoplasmas in Embryonating and Dead Embryonated Eggs. I.J. Pan,
K. Yamamoto, Y. Takahashi, M. Ogata. Faculty of Agriculture, University of
Tokyo, Tokyo, Japan
The authors had reported at the third IOM congress that the growth of 13 strains of
Mycoplasma and Acholeplasma species was divided into two patterns and the maximum viable
numbers of organisms were usually higher in dead embryonated than in embryonating eggs.
These results were obtained by CFU titration with partially sampled yolk (0.2 ml).
In order to complete the previously acquired data mentioned above, additional experiments
using M. gallinarum (PG 16), M. neurolyticum (PG 28), and M. hyorhinis (PG 29) were con-
ducted underthe same conditions as theprevious work, excepting the CFU titration, which was
done with the wholly harvested yolk in the present experiments. A dose of 104-106 CFU per egg
was inoculated into the yolk sac of the five-day-old embryonating eggs and the dead em-
bryonated eggs, which were four-day-oldembryonating eggs which had been chilled to death at
4°C oneday prior to the inoculation. Whole yolks ofthree to five eggs were harvested daily for
CFU titration, and the results werecompared with those ofprevious tests. The results obtained
were: (l) M. hyorhinis multiplied actively with a remarkably high CFU titer, whereas the
growths of M. gallinarum and M. neurolyticum showed relatively lower multiplication, and a
few-day lag phase was seen with the growth of M. neurolyticum; (2) M. gallinarum grew in
both embryonating and dead embryonated eggs with identical growth curves, but the latter
shovwed a higher CFU titer.
Conclusively, the results of the present experiments confirmed the previous data which had
been obtained by CFU titration with partially sampled yolk.
Characterization of Mycoplasma muris, a New Species from Urogenital Tracts of
Laboratory Mice. G. McGarrity. Institute for Medical Research, Camden, NJ;
D. Rose. Frederick Cancer Research Center, Frederick, MD; V. Kwiatkowski, A.
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Dion. Institute for Medical Research, Camden, NJ; D. Phillips. Population Coun-
cil, Rockefeller University, New York, NY; and J. Tully. Frederick Cancer Research
Center, Frederick, MD
Urogenital samples were obtained from mouse strains RIII and C57B1/6 and assayed for
mycoplasmas. Animals were obtained from inbred colonies maintained at this institution
(IMR). A total of 42 RIII and 32 C57B1/6 mice were sampled. Three isolations were made on
SP-4 medium from RIII mice; these were designated RIII-1, RIII-4, and RIII-8. These isolates
were similar in morphologic and biochemical characteristics. Strict anaerobic incubation in a
Gaspak [1] was required for growth. Repeat sampling ofone ofthese three mice six weeks later
also yielded a mycoplasma with the same characteristics.
The organisms hydrolyzed arginine but not urea, produced a film and spot reaction, and
were susceptible to 1.5 percent digitonin. Cholesterol was required for growth. Growth inhibi-
tion and plate epifluorescence showed that the isolates were serologically unrelated to 80
Mycoplasma species and unclassified serotypes. Transmission electron microscopic examina-
tion revealed the absence of cell wall material outside the plasma membrane of the organisms.
The organisms hemadsorbed to guinea pig erythrocytes and contained uridine phosphorylase
activity, converting 91.5 percent of '4C-uridine to '4C-uracil in 180 minutes. Thin layer chro-
matographic analysis ofDNA extracted from RIII-4 indicated this strainhad aguanine + cyto-
sine ratio of 24.9 + 1.0 moles percent.
Additional sampling did not detect related organisms in milk of RIII-4 or C57B1/6, or from
throat or fecal samples of RIII. Information is not available to relate these organisms to any
pathological state.
It is proposed that mycoplasmas with these characteristics belong to a new species, Myco-
plasma muris. Strain RIII is the type strain (American Type Culture Collection No. 33757).
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Morphological Observation ofAcholeplasma Colony underLight Microscopy (LM)
and Scanning Electron Microscopy (SEM). H. Konishi, Z. Yoshii. Yamaguchi
University School of Medicine Ube, Japan; and H. Ichimaru, M. Nakamura.
Kurume University School of Medicine, Kurume, Japan
Purpose: The basic construction ofAcholeplasma colonies was examined by LM and SEM.
Particularly, the so-called "nipple" was investigated in detail.
Materials and Methods: Strain A PG 8 of A. laidlawii, grown on PPLO agar, was used.
Whole or vertically cut colonies were prepared as LM specimens. Fixation was done with OSO4
vapor. Some samples were stained with toluidine blue. The colonies on the same plates were
used for SEM specimens. After fixation, they were air dried without hydration or with solvents
(acetone or ethanol). Critical point drying (CPD) or freeze drying (FD) by routine techniques
was used.
Observations andDiscussion: Some results obtained are shown in Figs. 1-6. Figures I and 2
are LM images of colonies, the former a whole profile ofcolonies with nipples and the latter a
vertically cut image of a colony stained with toluidine blue. Figure 3 is a SEM image of a ver-
tically cut colony. Figures 4 and 5 are both SEM images of colonies with AD, the former with
acetone hydration and the latter through ethanol. Figure 6 is a SEM image of a colony with
CPD through acetone hydration. From these results the folllowing observations were obtained
and discussed.
1. The basic construction ofthe colony ofA. laidlawii: A colony showed the entire image of
a mushroom, consisting of two parts (Figs. 2,3). One is a pileus (cap) and the other is a stipe
(stem). A so-called "fried egg image" or "nipple image" is only a description of the projective
image of the whole colony by LM.
2. Three-dimensional status of"nipple": The location of two parts, pileus and stipe, is very
clear. The pileus is the upper side, facing the air, and the stipe is the downward side, settling
into the agar layer (Figs. 2,3). This construction style provides an image ofa nipple (stipe) and of
a halo (pileus) by LM (Fig. 1). The central rising oftheAcholeplasma colony in the SEM image
was decided to be an artifact after AD (Figs. 4,5) or incomplete CPD. No rising occurred in
good CPD (Fig. 6).POSTER SESSIONS
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3. The mechanism ofthe central rising of a colony: The shrinking ratio ofthe pileus is larger
than that of the stipe. Therefore, the thinned pileus subsides and covers the stipe with less
shrinking. Finally, the central areaofthedried pileus remains aprotuberance on thestipe. This
phenomenon usually appears in the specimens with AD (Figs. 4,5) or incomplete CPD.
4. Cell population in a colony: The superficial layer of the pileus or the outer surface of the
stipe (in the agar) sometimes shows much more population than the inner area of both parts.
This fact can be seen in the section stained with toluidine blue (Fig. 2) or in the TEM image of
the thin section.
5. Sizes of colonies and appearances of"nipple": Colonial sizes are very variable, and a nip-
ple is seen even in the tiny colony. Therefore, the pileus and the stipe may originate at almost
the same time and grow in parallel.
6. Hydration and visibility of individual cell: These two factors are closely related to each
other. AD with hydration through ethanol or acetone provided higher visibility, whereas
without hydration the opposite occurs. The solvents might be the important agents for removal
of the superficial layer of the colony.
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A Relation between Gel Solidity and Colony Size. K. Kihara, S. Ishida. National In-
stitute of Health, Tokyo, Japan
Agar plate medium serves as a supplier of nutrients to organisms inoculated on its surface
and as a physical supporter of colonies. The purposes of this report are to establish a general
method of estimating the hardness of the plate medium and to find a quantitative relation be-
tween the colony diameter (CD) and the hardness.
Materials and Methods: Medium: Bacto PPLO Broth + Bacto Yeast Extract (0.8 percent)
+ horse serum (10 percent) + agar (0.8, 1.1, or 1.4 percent). Strains: M. gallisepticum, M.
hominis, M. iners, M. orale, M. salivarium, A. laidlawii A, and A. laidlawii Laidlaw. Gel
solidity meter (Fig. 1) and measurement of the hardness of the plate medium: By applying
various loads, the sustaining time (s-time) in which a surface ofplate medium sustained a given
load was measured. As dispersion of the s-time was large and extremely skew, the hardness
could not be expressed directly by the s-time. We therefore devised a statistical method in
which the s-time was used indirectly. The weight ofa load with which an s-time over 20 seconds
was obtained in 50 percent of the total measurements was used as the indicator of hardness of
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A. laidlawii A 0.478
A. laidlawii Laidlaw 3.645
*No significant deviation from linearity was demon-
strated.
CD was calculated by the number of division(s) on
micrometer scale.
the plate medium, which was expressed as gel solidity (GS, g/cm2). Measurement ofCD: The
diameter of well-isolated colonies from inocula containing 30-50 CFU was microscopically
measured.
Results andDiscussion: CD of 100 colonies collected from several inocula was measured. A
frequency distribution of CD approximately followed a normal distribution (data not shown).
The homoscedasticity of variance of CD obtained under different concentrations of agar was
not denied (data not shown).
A linear relationship existed among (i) GS and agar concentration (data not shown), (ii) CD
and agar concentration (Fig. 2), and (iii) CD and GS (Fig. 3).
Each test strain demonstrated a linear relationship between CD and GS, respectively
(Table 1).
In conclusion, GS is one of the factors of plate medium which quantitatively influence the
CD and can be analyzed by a statistical method. It is reasonable to lower the GS of the plate
medium in favor of better detection of mycoplasma.
Motility of Mycoplasma Strain G37. D. Taylor-Robinson, W. Bredt. Clinical Re-
search Centre, Harrow, Middlesex, UK, and Institut fur Allgemeine Hygiene und
Bakteriologie, Zentrum fur Hygiene, Freiburg, Germany
Introduction: In addition to the rotatory and undulating movements of spiroplasmas, glid-
ing motility has been observed in Mycoplasma pulmonis, M. gallisepticum, and M. pneu-
moniae [1]. Gliding mycoplasmas are different from non-motile species in cell shape and ultra-
structure. The most striking aspect is a pronounced head structure (leading part, terminal or
specialized structure), which shows distinctive ultrastructural details.
Glucose-fermenting mycoplasmas, different from all those recovered hitherto, were isolated
from the urethra of three of 13 men with non-gonococcal urethritis [2,3]. The term Myco-
plasma genitalium has been proposed for these organisms [4]. They have adherence properties
and are flask-shaped with a terminal structure similar to that seen in M. pneumoniae, so that it
was of interest to determine whether they also exhibited gliding motility. One of the strains,
G37, was examined.
Method: SP4 medium [5] containing 3 percent gelatin was inoculated with strain G37 or-
ganisms and then introduced into coverslip chambers [6,7]. The chambers were filled, in-
cubated at 37°C, and the organisms observed by means of an inverted Zeiss microscope with
phase contrast. Detailed drawings of the position ofthe organisms were made and movement
recorded on 16 mm cinefllm by means of Wild cinematograph equipment with time lapse, us-
ing 10, 30, and 120 exposures per minute.
Results andDiscussion: The organisms were elongated, appearing to consist of a frontal tip
structure, a thicker body, and a tail. The organisms moved in the direction of their tip struc-
ture, many in circles, often but not exclusively in a clockwise direction. The speed of the or-
ganisms was fairly constant, the average being about 0.1 m per second. This speed is not as
fast as that recorded previously for M. pulmonis and M. pneumoniae. But it is faster than that
of M. gailisepticum [1].
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The role that M. genitalium plays in genital or other human disease is unknown. However,
the existence of motility is yet another feature which suggests that this mycoplasma is patho-
genic because motility has been correlated with.the pathogenicity of the other mycoplasmas
which have been mentioned.
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Isolation and Identification of Mycoplasmas from Veterinary Biologics 1972-1981.
T.A. Koski, G.G. Christianson. United States Department of Agriculture, Animal
and Plant Health Inspection Service, National Veterinary Services Laboratories,
Ames, 10
A total of 6,773 biological materials, including cell lines, seed viruses, and finished com-
mercial lots of veterinary biologicals (mostly viral vaccines), were tested for mycoplasma con-
tamination in this laboratory during the past decade. These biologicals were produced by 36
manufacturers licensed by the USDA and these products represent 51 different vaccines or vac-
cine combinations. Of these vaccines, 15 were for poultry, 13 were for large animal species,
and 23 were for small animal species. One hundred and nineteen mycoplasmas were isolated:
111 from vaccines, five from virus vaccine seed stocks, and three from cell cultures used in vac-
cine production.
The highest mycoplasma contamination rates occurred in the first three years (1972-1974)
with 100 isolations. In the last seven years (1975-1981), the rate ofmycoplasma contamination
dropped dramatically to 19 isolations. The decrease in mycoplasma contamination is most
likely due to increased awareness of the problem, efforts in establishing the sources of con-
tamination, increased expertise in isolation ofmycoplasmas, and intensified surveillance by the
manufacturers. Fifty-seven mycoplasmas were identified: 36 were probably bovine strains (25
A. laidlawii, two M. bovoculi, seven M. arginini, two Acholeplasma sp.), six avian (M.
gallisepticum, 11 human (M. orale), and four swine (M. hyorhinis). Thus, the sources of vac-
cine contamination were probably from bovine (sera), avian (developing chicken embryo),
human (oral), and porcine origin.
Isolation of Mycoplasmas from Raccoon Dogs (Nyctereutes procyonoides viver-
rinus). Yasuo Kanamoto. Hiroshima Prefectural Institute of Public Health, Hiro-
shima, Japan; Hitoshi Kotani. Imamichi Institute for Animal Reproduction,
Ibaraki, Japan; Yoshiyasu Matsuo. Hiroshima University School of Medicine,
Hiroshima, Japan; and Manabu Ogata. Faculty of Agriculture, University of
Tokyo, Tokyo, Japan
An attempt was made to isolate mycoplasmas from raccoon dogs (Nyctereutesprocyonoides
viverrinus) caught in the wild. The results of our first investigation made on seven raccoon
dogs from April to June 1979 have been reported previously (Jpn J Vet Sci 43:267-271). Addi-
tionally, a survey was made to isolate mycoplasmas from newly captured raccoon dogs from
March to April 1981. This communication describes the results of these studies.
Attempts were made to isolate mycoplasmas from the oral cavity, nasal cavity, external ear,
rectum, vagina, and prepuce of 12 raccoon dogs.
The liquid medium (T-broth) used for isolation of genus Ureaplasma consisted of 80 ml of
PPLO broth (Difco), 15 ml of horse serum, 5 ml of 25 percent (w/v) yeast extract, 1 ml of
100,000 units ofpenicillin G, 1 ml of2.5 percent thallium acetate, I ml of 10 percent urea solu-
tion, and 0.002 percent phenol red. The pH was adjusted to 6.0. The solid medium (T-agar)
used consisted of the same ingredients as T-broth, except that 2.5 ml of phosphate bufferPOSTER SESSIONS
(1.5M KH2PO4:1.5M Na2HPO4 = 7:3) and 0.8 percent purified agar (Oxoid) were added. The
liquid medium used for isolation of genus Mycoplasma consisted of 70 ml of PPLO broth
(Difco), 20 ml of horse serum, 10 ml of 25 percent yeast extract, 1 ml of 2.5 percent thallium
acetate, I ml of 100,000 units of penicillin G, and 0.002 percent phenol red. For the solid
medium, 1.2 percent Bacto agar (Difco) was added to the liquid medium, excluding phenol red.
Mycoplasmas were isolated from the oral cavity (11/12, 92 percent), nasal cavity (3/12, 25
percent), rectum (6/12, 50 percent), and vagina (1/7, 14 percent). Ureaplasmas were isolated
from the oral cavity (5/12, 42 percent), nasal cavity (4/12, 33 percent), and rectum (1/12, 8
percent). A total of 36 strains were examined by biochemical and serological tests.
Nine ureaplasma strains derived from raccoon dogs were serologically compared with urea-
plasma strains isolated from man, monkey, cattle, goat, sheep, cat, chicken, and dog. They
were found to belong to one of the four serogroups of canine ureaplasmas (Jpn J Sci
41:639-646), but were antigenically distinguished from man, monkey, cattle, goat, sheep, cat,
and chicken.
Twenty-seven strains ofmycoplasmas were cloned and ofthem nine strains which fermented
glucose were identified as Mycoplasma edwardii. The remaining 18 strains which were negative
for fermentation ofglucose, and for hydrolysis of arginine or urea were serologically different
from eleven reference strains such as M. edwardii, M. canis, M. cynos, M. spumans, M.
maculosum, M. molare, M. opalescens, M. feliminutum, M. bovigenitalium, M. pulmonis,
and M. neurolyticum but cross-reacted with Mycoplasma sp. (strain LM2) reported previously
(Jpn J Vet Sci 43:267-271).
This is the first report for isolation of M. edwardii and ureaplasmas from raccoon dogs.
Mycoplasma iowae-An Avian Mycoplasma with Unusual Properties. Janet M.
Bradbury. University of Liverpool Veterinary Field Station, Neston, Wirral,
England
Mycoplasma iowae (formerly Iowae 695, avian serovar I) was first classified as a separate
serovar but was later shown to be antigenically related to avian serovars J, K, N, Q, and R. As
a group these mycoplasmas seem to be unusual in a number of their biochemical, immuno-
logical, and pathogenic properties.
1. BiochemicalProperties: Members of the M. iowae group metabolize both glucose and ar-
ginine and are also able to grow in the presence of 1 percent bile salts [Barber, Fabricant: Appl
Microbiol 21:594, 1971]. These properties make them unique among the established avian
mycoplasmas.
2. Immunological Properties: Variation in antigenic composition within the group has been
reported, and in order to identify an isolate it may be necessary to use antiserum to more than
one strain in serological tests [Fabricant: personal communication]. Results ofindirect fluores-
cent antibody (IFA) tests in our laboratory support this view. For example, antiserum to the
reference strain 695 has sometimes failed to identify isolates which give strong positive reac-
tions with antisera to other members ofthe group. Another feature of someM. iowae strains in
IFA tests is variation in fluorescent intensity between colonies of similar size on the same agar
plate. This gives the appearance of a mixed culture but further tests do not reveal a mixture.
M. iowae seems to be less able to provoke a humoral immune response in chickens and
turkeys than other pathogenic avian mycoplasmas. For example, when 34 chicks and 29 turkey
poults were inoculated with one of five strains of M. iowae at one day of age, only one chick
had developed detectable agglutinins by six weeks. In another experiment, adult chickens were
each given two intravenous inoculations to produce antisera to 12 different avian mycoplasma
species, and it was found that the birds that were inoculated with M. iowae (two strains) re-
quired a longer course of immunization to produce sera of equivalent potency to the others.
3. Pathogenic Properties: Some strains ofM. iowae were found to cause high levels of mor-
tality when inoculated into the yolk sac ofchicken and turkey embryos at seven days. This was
particularly noticeable in turkey embryos in which all of the strains tested proved to be lethal.
Most embryos died in the late stages ofincubation and exhibited a variety ofabnormalities, in-
cluding stunting, edema, and congestion. The natural infection in commercial turkeys is
thought to cause economic loss in terms of reduced hatchability.
When inoculated into young chickens and turkeys, some M. iowae strains caused a low in-
cidence ofarthritis and ruptured digital flexor tendons. The turkeys also developed a variety of
bone deformities. These findings are detailed in another presentation to this conference.
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